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ABSTRACT 
Microfluidic bio-assays have emerged as the most privileged solutions and provide the basis for 
the realization of miniaturized bio-analytical systems and clinical diagnostic devices that are 
portable, user-friendly and cost-effective (Lab-on-a-chip). Two important steps that are 
implemented in a microfluidic bio-assay are: (a) the immobilization and/or patterning of target-
specific bio-molecules on the surface of a microfluidic channel, for selectively capturing bio-
targets like antigens or pathogens, followed by (b) sensitive detection of the bio-targets. In this 
thesis, we demonstrate microfluidic bio-assays based on novel methods for generating protein-
patterns and on sensitive detection of the bio-targets.  
First, we introduce a simple and fast method for creating protein micropatterns both on a bare 
substrate and in-situ inside a microfluidic channel, in a matter of minutes, through electrostatic 
self-assembly of pre-functionalized magnetic beads. A lift-off patterned positively-charged 
aminosilane layer is used as the template for immobilizing the protein-coated negatively-
charged beads. The number and arrangement of the beads can be well-controlled by altering the 
silane template design.  
Subsequently, we use patterned beads as assay substrates for performing on-chip bioassays. We 
demonstrate highly-sensitive full on-chip sandwich immunoassays for single and multi-analyte 
detection using beads as assay substrate. We successfully explored the possibility to lower the 
detection limit of immunoassays by concentrating the target antigens on a very small number of 
patterned beads. We also present the application of bead patterns as a platform for immuno-
separation, culture and analysis of target (cancer) cells. 
Finally, we demonstrate a rapid on-chip immuno-histo-chemical assay on breast cancer tissues. 
We use luminescent lanthanide probes in place of conventional fluorescent probes, as labels for 
detection antibodies, for sensitive detection and quantification of biomarkers. Thanks to the 
time resolved microscopy and luminescent probes, the background noise due to the 
autofluorescence of the samples (i.e. tissue, cells) and microfluidic chips is successfully 
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eliminated resulting in an improved signal-to-noise ratio when compared with the fluorescent 
microscopy results. Our assay results fully agree with the clinical analyses outcome, and this 
opens perspectives for a fully-integrated cancer detection platform for bedside diagnostics. 
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Immunocytochemistry – Immunohistochemistry 
 
 
 iii 
 
ZUSAMMENFASSUNG 
Mikrofluidische Biotests haben sich zu einem bevorzugten Diagnoseverfahren entwickelt und 
legen den Grundstein für die Entwicklung von miniaturisierten Bioanalyse-Sytemen, die 
tragbar, benutzerfreundlich und rentabel sind (Stichwort „Lab-on-a-Chip“). Zwei wichtige 
Merkmale eines mikrofluidischen Biotests sind: (a) die Immobilisierung und/oder das 
Definieren von Mustern von Molekülen, die spezifisch an die nachzuweisende Substanz 
binden, auf der Oberfläche eines mikrofluidischen Kanals, um selektiv biologische 
Zielmoleküle wie z.B. Antigene und Pathogene einzufangen, gefolgt von (b) einem 
hochempfindlichen Nachweis dieser Bio-Analyte. In dieser Doktorarbeit werden 
mikrofluidische Biotests vorgestellt, die auf neuartigen Methoden zum geordneten Aufbringen 
von Proteinen auf Oberflächen und auf dem hochempfindlichen Nachweis von Zielmolekülen 
basieren. 
Zunächst stellen wir eine einfache und schnelle Methode vor, mittels der Proteine innert 
weniger Minuten mikrometergenau sowohl auf einem freiliegendem Substrat als auch in situ in 
einem Mikrokanal geordnet angebracht werden können, indem die elektrostatische 
Selbstassemblierung von zuvor funktionalisierten magnetischen Kügelchen genutzt wird. Als 
Schablone für die Immobilisierung der proteinbehaftetenund negativ geladenen Kügelchen 
wird eine lift-off-Schicht aus positiv geladenem Aminosilan verwendet, in die das gewünschte 
Muster eingeprägt ist. Die Zahl und Anordnung der Kügelchen kann gut gesteuert werden, 
indem das Muster in der Silanschablone geändert wird. 
Anschliessend setzen wir diese regelmässig angeordneten Kügelchen als Substrat für Biotests 
auf einem Mikrochip ein. Wir verwenden diese Kügelchen in höchst empfindlichen Sandwich-
Immunoassays, die vollständig auf einem Mikrochip durchgeführt werden und mittels derer 
einzelne und mehrere Analyte nachgewiesen werden können. Wir haben erfolgreich die Grenze 
der Nachweisbarkeit in Immunoassays gesenkt, indem wir die Ziel-Antigene auf einer sehr 
geringen Anzahl von regelmässig angeordneten Kügelchen konzentrierten. Ferner zeigen wir, 
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wie diese Kügelchen-Strukturen in einem System zur Immunoseparation, Zellzucht und 
Analyse von (krebsbefallenen) Ziel-Zellen angewendet werden können. 
Schliesslich stellen wir ein schnelles, immunohistochemisches Verfahren zum Nachweis von 
Brustkrebs auf einem Mikrochip vor. Zur Markierung der Detektions-Antikörper, für einen 
empfindlichen Nachweis und zur Quantifizierung der Biomarker verwenden wir 
luminiszierende Lanthanid-Sonden anstelle von herkömmlichen fluoreszierenden Sonden. 
Dank zeitaufgelöster Mikroskopie und dieser luminiszierender Sonden kann das 
Hintergrundrauschen erfolgreich eliminiert werden, was, verglichen mit Ergebnissen aus der 
Fluoreszenz-Mikroskopie, ein verbessertes Signal-Rausch-Verhältnis zur Folge hat. Die 
Ergebnisse unserer Assays stimmen vollauf mit Resultaten aus klinischen Analysen überein. 
Daraus ergeben sich Möglichkeiten zur Herstellung eines vollstufigen Systems zum 
ambulanten Nachweis von Krebs. 
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1.1 Introduction 
During the last three to four decades, the field of micro- and nanofabrication has made a rapid 
progress mainly fueled by the challenging needs of microelectronics industry. This is reflected 
in the famous Moore’s law which predicts that the density of transistors in a given area of an 
integrated electronic chip will keep doubling every year (see Fig. 1.1)1. Though 
microfabrication techniques were mainly developed for integrated circuit manufacturing on 
silicon, with time, they formed the basis for the development of microscale devices and systems 
(commonly referred as MEMS in USA and microsystems in Europe) on silicon and as well on 
other common materials, like glass, polymers etc.2. These devices can be mass-produced with 
the help of modern microfabrication equipments and well-established processes. Since the 
beginning of 1990’s, several MEMS products, particularly for physical parameters sensing  e.g. 
acceleration, force, pressure etc., have become part and parcel of our modern day consumer 
products like automobiles. Driven by this market success, subsequently, a strong interest in the 
development of chemical and bio-sensing microsystems started to evolve. As chemical and bio-
microsensors mostly need liquid samples (e.g. blood, urine) for analyte detection, the concept 
of microfluidics formed/forms the edifice for the former’s development. Now many inter-
disciplinary research groups are working in the direction of scaling down the analytical 
laboratory in the microscale format based on microfluidics. In a decade of time, this field has 
made its own mark in the domains of science and technology and it is widely known as that of 
“micro total analysis systems (μTAS)” alias “labs-on-a-chip”. 
 
Figure 1.1. The evolution of Moore’s law over three to four decades in a graphical form3. 
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1.2 Lab-on-a-chip concept 
A lab-on-a-chip is an integrated microfluidic device or platform that aims to incorporate several 
phases of sample analysis viz. sample preprocessing, analyte separation and detection, in a 
single chip format. A typical integrated microfluidic chip comprises a microfluidic channel 
with passive or active fluid control components for sample valving, pumping, mixing etc., and 
integrated electronic/optical components/modules for analyte detection (Fig. 1.2a). For 
instance, Fig 1.2b schematically illustrates different modules of an integrated microfluidic 
system used for cell based bio-chemical analysis. 
 
 
Figure 1.2. Schematic illustration of the lab-on-a-chip concept (a) and a lab-on-a-chip system 
for cell-based bimolecular assays (b). (b) is from reference4  
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Clearly, for developing a successful lab-on-a-chip, a confluence of expertise from physics, 
chemistry, biology and engineering is required, thus making this field highly cross-disciplinary. 
Lab-on-a-chip systems have already started to enter the market and one good example is the 
Agilent’s product “Protein LabChip” used for protein assays (see Fig. 1.3)5. A recent market 
research report, has predicted a huge market ($3 billion) world-wide for microfluidics-based 
analytical devices and in particular for diagnostics by 2014, i.e. in 3 years from now6. 
 
 
Figure 1.3. Agilent’s lab-on-a-chip product for protein analysis (From reference5) 
 
The wide popularity behind the lab-on-a-chip systems can be attributed to the following 
advantages: 
• Reduced sample and reagent consumption 
• Disposable microfluidic cartridges (single-time use) 
• Fast analysis 
• Portable 
• Low operational power 
• Mass producible 
• Cost-effective 
• High-throughput automated analysis 
 
The recent developments in the domain of μTAS/ lab-on-a-chip domain has been reviewed by 
A. Manz and his colleagues in a series of review articles7-9. 
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1.3 Thesis scope and outline 
Protein patterning forms the basis for several bio-assay studies viz. immunoassays, protein-
kinetics studies, high-throughput protein-protein interaction studies, spatially controlled cell 
culture for drug-screening etc.. Unlike DNA, proteins are fragile and it is essential to handle 
them in a wet environment (i.e. in a buffer solution). Hence, to perform these bio-assays in a 
microfluidic format, in-situ protein patterning inside the microfluidic channel is essential. 
Additionally, the success of any diagnostic system clearly depends on the detection strategy 
used and its limit-of-detection (LOD); hence pushing the LOD as down as possible is very 
important to have a highly-sensitive lab-on-a-chip device. This thesis focuses on addressing the 
topics of in-situ protein patterning and LOD by developing novel and yet simple methods. In 
short, the objectives of this thesis are two-fold: firstly to develop a simple method for 
patterning proteins in-situ inside a microfluidic chip and secondly to offer new strategies for 
high-sensitivity detection of antigens and biomarkers from biological samples. 
 
In Chapter 2, a short overview of four different topics, which can be considered as four `pillars´ 
on which this thesis is based, are presented. Firstly we introduce the structure and properties of 
magnetic beads and subsequently, basic microfluidic concepts are presented. As the third part, 
the concept of an immunoassay and different types of immunoassay are explained. As the last 
part of this chapter, basic notions on the subject of cancer and its diagnostics are presented. In 
Chapter 3, different techniques and approaches in the field of protein micropatterning, bead-
based microfluidic immunoassays and microfluidic cancer diagnosis, along with their merits 
and demerits,  are presented. 
 
In Chapter 4, a self-assembly-based approach for patterning protein-coated beads on glass 
substrates is presented. Also extension of this technique for in-situ protein patterning inside a 
microfluidic chip is demonstrated. In Chapter 5, two different microfluidic bio-assay 
applications, based on the previously introduced bead-based protein micropatterning approach, 
are presented. In the first part, methods and results pertaining to highly-sensitive bead-based 
microfluidic immunoassays are presented and in the following part we demonstrate the 
application of patterned beads as a common platform for microfluidic target cell separation, 
culture and analysis. In Chapter 6, we demonstrate microfluidic immunocytochemical and 
immunohistochemical assays on breast cancer cells and breast cancer tissue samples, 
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respectively. We show how the time-resolved luminescence detection can be a better 
alternative to the conventional fluorescent detection for efficient cancer diagnostics in a 
microfluidic format. 
 
Finally a summary of this thesis along with some exploratory ideas for future work are 
presented in Chapter 7. 
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Analytical Chemistry 2004;76:3373-85. 
8. Reyes DR, Iossifidis D, Auroux PA, Manz A. Micro total analysis systems. 2. 
Analytical standard operations and applications. Analytical Chemistry 2002;74:2623-36. 
9. Dittrich PS, Tachikawa K, Manz A. Micro Total Analysis Systems. Latest 
Advancements and Trends. Analytical Chemistry 2006;78:3887-907. 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 2: Background 
7 
 
    2 BACKGROUND  
Contents 
 
2  Background ............................................................................................................................... 7 
2.1 Functionalized Magnetic beads........................................................................................... 8 
2.1.1 Structure of beads ........................................................................................................ 8 
2.1.2 Magnetic properties of beads ....................................................................................... 9 
2.2 Microfluidic principles...................................................................................................... 13 
2.2.1 Pressure driven flow .................................................................................................. 13 
2.2.1 Reynolds number and flow regimes .......................................................................... 14 
2.2.2 Diffusion of molecular species in a microfluidic channel ......................................... 15 
2.2.3 Surface area to Volume Ratio .................................................................................... 16 
2.3 Immunoassay .................................................................................................................... 16 
2.3.1 What is an immunoassay? .......................................................................................... 16 
2.3.2 Antibodies .................................................................................................................. 17 
2.3.3 Immunoassay categories ............................................................................................ 18 
2.4 Cancer ............................................................................................................................... 19 
2.4.1 Basics of Cancer ......................................................................................................... 19 
2.4.2 Cancer diagnosis and therapy..................................................................................... 21 
2.5 References ......................................................................................................................... 23 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 2: Background 
8 
 
The four central topics or keywords around which this whole thesis revolves are viz. 
functionalized magnetic beads, microfluidics, immunoassay and cancer / cancer diagnostics. In 
this chapter, the main introductory concepts pertaining to these four topics are presented.     
2.1 Functionalized Magnetic beads 
Magnetic micro- and nanospheres, which are commonly known as magnetic beads or simply 
beads, are being widely used as a platform for the purification and analysis of various 
biomolecules (proteins, DNA etc.) and cells, both on laboratory scale and on a microscale i.e. 
the lab-on-a-chip format1-3. This trend can be attributed to several advantages: (a) commercial 
availability of a wide range of tailor-made surface-functionalized beads, (b) a large bead 
surface area for efficient capture of bio-targets, and (c) the possibility to manipulate beads 
using external magnetic fields without causing their agglomeration. In this section, a brief 
overview of the magnetic properties of beads and their configuration are presented. This section 
is based on and adapted from references4, 5.  
2.1.1 Structure of beads 
Typically a magnetic bead comprises a core made of primary magnetic nanoparticles 
encapsulated in a polymer shell (see Fig. 2.1). The former provide the magnetic 
content/character to the beads, while the latter serves two purposes: providing firstly a matrix 
for protecting the primary magnetic nanoparticles against degradation and secondly a base for 
physically or chemically grafting bio-molecules, surfactants and/or other chemical moieties. 
 
 
 
Figure 2.1. Structure and configuration of superparamagnetic particles or magnetic beads. 
Schematic illustration of (a) a (bio)chemically functionalized magnetic bead with its primary 
magnetic nanoparticles embedded in a protective matrix and (b) with its primary nanoparticles 
decorated around an inner polymer core and sorrounded by a protective polymer matrix-shell. 
(c) Scanning electron microscopy graph of 2.8 μm streptavidin-coated magnetic beads 
(Invitrogen, Switzerland). 
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The surface chemistry of the beads can be tailored in such a way that an electrostatic and/or 
steric repulsion between the adjacent beads develops, when they are dispersed in a liquid 
medium, thus resulting in a stable dispersion of magnetic beads. 
2.1.2 Magnetic properties of beads 
As mentioned before, magnetic beads are comprised of several primary magnetic nanoparticles 
which form the basis for their magnetic behavior. Magnetic nanoparticles are usually 1-100 nm 
in size and are made of ferromagnetic or ferrimagnetic materials. The most common material 
choice for primary nanoparticles is iron oxide (maghemite Fe2O3 or magnetite Fe2O4) or other 
more complex metal-iron oxide alloys (e.g. cobalt-iron-oxide). 
 
Each atom or molecule of the magnetic materials exhibits an intrinsic magnetic moment 
contributed by the spin and orbital motion of the electrons in the atom6. The total magnetic 
moment or magnetisation (m) of a material is the vector sum of all the individual magnetic 
moments (also called as spins). For a ferromagnetic material, at a temperature of absolute zero, 
these magnetic moments (represented as arrows in Fig. 2.2) are aligned to each other in a 
parallel manner and are oriented in the same direction (see Fig. 2.2a.). In case of a 
ferrimagnetic material, the individual magnetic moments are parallel and they are oriented 
opposite to each other, but resulting in a non-zero total magnetization (Fig. 2.2b). However, at 
temperatures above a critical temperature, called as Curie temperature (Tc), the magnetization 
of the ferromagnetic and ferrimagnetic materials becomes zero, resulting in a paramagnetic 
state (Fig. 2.2c). This effect is due to the large thermal fluctuations at Tc, which completely 
disorient and randomize the arrangement of individual magnetic moments. 
 
 
 
Figure. 2.2. Spin arrangement of (a) ferromagnetic, (b) ferrimagnetic and (c) paramagnetic 
material. 
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Ferromagnetic and ferrimagnetic materials exhibit long-range spin ordering at the magnetic 
domain scale. The latter ranges from less than 10 to 100 nanometers, depending on the 
material. A typical ferromagnetic or ferrimagnetic sample is constituted of magnetic domains –
in which the spins are pointing in the same direction- separated by domain walls. The 
application of an external magnetic field H on a magnetic material constrains the magnetic 
domains to align with the magnetic field. Thereby, a macroscopic magnetic moment of the 
material is induced: 

=
=
k
i 1
iµm  (A.m2) 
where µi is the magnetic moment of the domain i, k the number of domains and m the total 
magnetic moment of the material. 
The response of a magnetic material to an external magnetic field is expressed in the magnetic 
induction (B) and is defined as: 



+= HMB 0µ  (T) 
where µ0 is the magnetic permeability of the vacuum, and M the magnetization or magnetic 
moment density of the material, defined as M = m / V, with V the sample volume. 
For a linear and homogeneous material, the relation between M and H is given by. 
HM mχ=  (A.m-1) 
where χm is the magnetic susceptibility of the material. Here, the demagnetization effects are 
not taken in to account. 
 Chapter 2: Background 
11 
 
 
Figure 2.3. Typical hysteresis loop of a ferromagnetic or a ferrimagnetic material. After 
synthesis, the material exhibits no magnetization (1). The curve is characterized by a magnetic 
saturation induction (Bs), a remanant magnetic induction (Br) and a coercive field Hc. 
In a ferromagnetic or ferrimagnetic material, the relations between M, H and B are not 
linear and often history-dependent. The magnetic response to the application of an external 
magnetic field is characterized by a hysteresis loop. Fig. 2.3 presents a typical hysteresis loop 
of a ferromagnetic or a ferrimagnetic material. After synthesis, the material exhibits no 
macroscopic magnetization. When applying an external magnetic field H, the magnetic 
induction increases to a saturation value (Bs). The material has a remanant magnetic induction 
(Br) when the external applied field H = 0 and a coercive field Hc at B = 0 (the field needed to 
demagnetize the material). 
As the sample size decreases below a critical particle size (Dc), the material is no longer 
made up of an assembly of magnetic domains, but it consists of a single domain. In this case, 
the thermal fluctuations of the spins do not permit a stable magnetization for the nanoparticle. 
Therefore, the nanoparticle has no magnetic moment without an external magnetic field, but 
exhibits a strong magnetization in the presence of even a small magnetic field. These particles 
are called superparamagnetic particles (Fig. 2.4). As the magnetic beads are made of 
superparamagnetic primary nanoparticles, the former also exhibit superparamagnetic behavior, 
as shown in Fig. 2.5. 
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Figure 2.4. (a) Size-dependence of the coercivity of a magnetic particle. When the particle size 
decreases below some critical particle size (Dc), the particle is monodomain. Hc reaches its 
maximal value for Dc, and is 0 below the superparamagnetic particle size limit. (b) Typical 
hysteresis loop of a superparamagnetic particle. (From7) 
 
 
Figure 2.5. (a) One micron carboxyl (-COOH) functionalized magnetic beads (Invitrogen), 
dispersed in an aqueous phase; (b) formation of pearl-like chains under a uniform magnetic 
field B. (c) Immediately after field is switched-off, all the chains break, the beads disperse and 
resume their Brownian motion owing to their superparamgnetic character. 
 
 Chapter 2: Background 
13 
 
2.2 Microfluidic principles 
As mentioned before, microfluidics is widely used for bio-chemical analysis and for bio-assays 
due to the unique fluidic behavior at the microscale and the general merits of down-scaling and 
miniaturization. In this section, important physical principles relevant to microfluidics are 
therefore briefly explained. As the reagent and analyte solutions are water-based fluids, they 
can be assumed as incompressible and as Newtonian fluids. The term incompressible implies 
that the density (ρ) of the fluid remains constant in space-time, whereas the term Newtonian 
implies that the viscosity (ߟ) of the fluid does not depend upon the forces acting on it but only 
on the ambient temperature and pressure. For comprehensive reading on this topic we refer to 8, 
9
. 
2.2.1 Pressure driven flow 
 
 
Figure 2.6. Velocity profile of a flow in a channel with a pressure difference p over the 
channel inlet and outlet. (From reference 10) 
 
Pressure driven flow is the common method used for continuous mode transport of liquid 
samples inside the microfluidic channels. In a laboratory set-up, this is quite often 
accomplished using syringe pumps. The velocity field (vሬԦሻ profile of such a fully developed 
pressure driven flow is parabolic, as shown in Fig. 2.6.  The fundamental equation, known as 
the Navier-Stokes equation, governing the fluid-flow dynamics and hence the velocity field (vሬԦ) 
of an incompressible Newtonian fluid is given below: 
 
ߩ ቈ߲vሬԦ߲ݐ ൅  ൫ vሬԦ. ׏ሬԦ൯vሬԦ቉ ൌ  െ׏ሬԦ݌ ൅ ߟ׏
ଶ vሬԦ ൅ Ԧ݂ 
 
This equation is derived from the principle of mass and momentum conservation (Newton’s 
second law). 
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The left side of the equation representing the fluid inertial force density is composed of time-
dependent (డ୴ሬԦడ௧) and convective space-dependent effects (൫ vሬԦ. ׏ሬԦ൯vሬԦ). According to Newton’s 
second law, this equation states that fluid inertia is equal to the sum of force densities acting 
upon the fluid. The force densities can be decomposed into: 
- internal forces (stress): pressure gradient force (െ׏ሬԦ݌) and viscous forces (ߟ׏ଶ vሬԦ) 
- external forces Ԧ݂ ൌ ∑ Ԧ݂௜ ௜ (such as gravity or centrifugal forces) 
2.2.1 Reynolds number and flow regimes 
The Reynolds number (ܴ௘) is a dimensionless parameter used for characterizing the fluid flow 
regime as laminar or turbulent. It is defined as the ratio between inertial and viscous forces. The 
Reynolds number can be calculated using the equation given below:  
 
ܴ௘ ൌ  
ߩݑܦ௛
ߟ  
 
where ݑ can be defined as the mean flow velocity and ܦ௛ is the hydraulic diameter of the flow 
channel. The value of ܦ௛ depends on the cross-sectional dimensions i.e. the width (ݓ) and the 
height (݄) of a flow  and it is defined as 4 × the ratio between cross-sectional area and its 
perimeter. In microfluidics, rectangular channels are common and ܦ௛ for a rectangular channel 
can be computed using the equation below: 
 
ܦ௛ ൌ  
2. ݓ. ݄
ݓ ൅ ݄ 
 
The flow is laminar for ܴ௘ ൏ 2000 , where viscous forces dominate. In this regime, all fluid 
elements move deterministically along distinct and traceable stream lines. When  ܴ௘ ൐ 2000 
inertial forces are dominant resulting in a turbulent flow regime. Turbulent flow is 
characterized by a random transverse motion of the fluid with respect to its flow direction. The 
transition from one regime to the other is progressive and not clearly defined, creating a zone 
corresponding to a transitional regime. 
 
In this thesis, we use microfluidic channels with a typical cross-section of ݓ ൌ ݄ ൌ
100  µm and a maxium flow rate of around 100 nL/s. As the sample and reagent solutions are 
aqueous solutions, it can be assumed that their ρ and ߟ are same as that of water i.e. 998 kg m-3 
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and 1.10-3 kg m-1 s-1 (Pa s), respectively. For these values we get a ܴ௘ ൌ  10ି଼, which clearly 
indicates that the operation is well within the laminar flow regime. As the flow regime in a 
microfluidic channel is laminar, two or more streams of different fluids can be simultaneously 
flown inside a single channel without any significant interaction between them except for a 
slight interfacial mixing due to the diffusion effects (see Fig. 2.7). 
 
 
 
Figure 2.7. Finite Element Method simulation result showing the diffusion based mixing at the 
interface between two adjacent laminar streams flowing through a microfluidic channel. The 
arrows indicate the typical parabolic velocity profile of the fully developed pressure-driven 
flow inside the channel. (From reference 4) 
 
2.2.2 Diffusion of molecular species in a microfluidic channel 
Due to the small length scales, the total diffusion of molecules across a microfluidic channel is 
fast, usually a few seconds to a few tens of seconds. Molecular diffusion occurs via Brownian 
motion and the time required for the diffusion ݐௗ (s) of a molecule, in a single dimension, over 
a distance ܮ in a fluid at rest can be calculated by: 
 
ݐௗ ൌ  
ܮ
2ܦ
ଶ
 
 
in which ܦ (m2/s) is diffusion coefficient of the molecule. 
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This means, for a protein of molecular weight (mW) 150 kDa and a ܦ of 5×10-11 m2/s that is 
present inside a 60 μm high microfluidic channel it will take only 36 seconds to reach the 
surface of the latter and get captured by the surface-functionalized antibodies. In short, as 
diffusion times are very short on a microscale, bio- and chemical analysis in a microfluidic 
channel can be performed in a rapid manner and using small reagent volumes, when compared 
with the traditional laboratory methods (e.g. diffusion times in microtiter plates can range from 
30 minutes to few hours). 
2.2.3 Surface area to Volume Ratio 
One of the important advantages of a microchannel is its large surface area when compared 
with its volume. The surface to volume ratio (SVR) ሺmˉଵሻ of a rectangular microfluidic channel 
can be calculated using the equation given below: 
 
SVR  ൌ  2Lሺw ൅ hሻLwh   
 
where L (m), w (m) and h(m) are the length, the width and the height of the microchannel, 
respectively. 
 
For example, the (SVR) for a microfluidic channel of volume 200 nL and dimensions             
20 mm (L) × 100 μm (w) × 100 μm (h) is as large as 4 × 104 m-1. The large SVR of a 
microfluidic chip, in case of on-chip biochemical analysis, enables the functionalization of a 
large number of receptor molecules on the microchannel walls, which thus increases the 
interaction possibility between the analyte molecules and the surface receptor molecules. 
2.3 Immunoassay 
2.3.1 What is an immunoassay? 
An immunoassay is a test used for the detection and quantification of bio-chemical targets or 
antigens based on the specific interaction and complexation between the antibodies (Ab) and 
antigens (Ag). An Immunoassay usually employs a label (e.g. a fluorescence dye) for detecting 
the Ab-Ag complex formed during the assay. The Ab-Ag complex is highly stable and widely 
referred to as immuno-complex in the literature. 
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Ab + Ag            Ab-Ag (immuno-complex) 
 
Due to its high specificity and affinity, immunoassays play a major role and are commonly 
applied in clinical diagnostics, detection of narcotics and chemical warfare agents, drug 
analysis, food quality testing, environmental monitoring etc. 
2.3.2 Antibodies 
In higher mammals, antibodies are the proteins which are produced by the body’s defense cells 
(B lymphocytes) to fight against and eliminate the pathogens, i.e. antigens that are either 
invading or that have invaded the body. These antibodies are commonly known as 
immunoglobulins. Depending on the differences in their size, charge, composition and content, 
immunoglobulins can be classified into five isotypes viz. IgG, IgM, IgA, IgD, IgE. Out of this 
IgG is the most abundant in the blood and other tissue liquids and hence mostly used in 
immunoassays. The basic structure of an IgG antibody, which is typically Y-shaped, is 
schematically shown in the Fig. 2.8. Antibodies can be further classified as monoclonal or 
polyclonal. Though, in general, antibodies specifically recognize and attach to their antigens, 
monoclonal antibodies are highly specific and can bind only to a single specific site on an 
antigen whereas polyclonal antibodies can recognize and bind to multiple sites of an antigen. 
Polyclonal and monoclonal antibodies are derived from multiple cell lines and a single type of 
cell line, respectively. 
 
 
Figure. 2.8. Schematic representation of the basic antibody (IgG) structure.  
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2.3.3 Immunoassay categories 
 
 
 
Figure 2.9. Schematic illustration of sandwich immunoassay methods and their corresponding 
resultant calibration curves corresponding to (a-b) competitive type and (c-d) non-competitive 
type. 
 
Immunoassay techniques can be broadly classified as competitive and non-competitive. In the 
case of a competitive immunoassay the unlabeled target Ag (analyte/sample) competes with 
dye-labeled Ag for binding with Ab (Fig. 2.9a). As a result, low signal from the measurement 
means that the concentration of the Ags is relatively high and vice-versa. Thus the amount of 
target Ag in the test sample is inversely related to the magnitude of the signal measured in the 
competitive format (Fig. 2.9b). 
 
In the case of a non-competitive (also known as sandwich) assay first the target Ag is captured 
by the un-labeled Ab (capture Ab) and thereafter detected using dye-labeled Ab (detection Ab). 
The non-competitive assay is schematically illustrated in the Fig. 2.9c.   A capture Ab is 
immobilized at the surface of the reaction chamber. A solution containing the target Ag is 
introduced in the reactor and immuno-complexes between the capture Ab and target Ag are 
formed. After a washing step, the Ab-Ag complex is exposed to a detection Ab tagged with a 
calorimetric, fluorescent or electrochemical label. For colorimetric detection, the detection Ab 
is labeled with an enzyme that reacts with substrate molecules in solution changing the colour 
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of the solution. For fluorescence and electrochemical detection, the detection Ab is labeled with 
an enzyme that reacts with substrate molecules in solution to produce fluorescent or 
electrochemical molecules that are detected using an appropriate detector/sensor. Instead of 
using an enzyme label, it is also possible to directly use a fluorescent- dye-labeled detection 
Ab. An Immunoassay that employs enzyme-labeled and fluorescent-labeled detection Abs for 
detection is known as enzyme linked immunosorbent assay (ELISA) and fluorescent 
immunosorbent assay (FIA), respectively. As shown in Fig. 2.9d, in the case of sandwich 
immunoassay, Ag concentration is directly proportional to the measured signal. As ELISA and 
FIA offers high sensitivity and specificity, they are the most commonly utilized immunoassay 
protocols till date. 
 
In 1973, Dandiker et al.11 have developed the fluorescent polarization immunoassay (FPI). It 
consists of detecting the variation of fluorescence polarization during bimolecular interactions 
between a fluorescent labeled Ab and its Ag. As a sandwich immunoassay is generally 
performed on a surface, different surface detection methods have been investigated, like 
Surface Plasmon Resonance (SPR)12, a surface-sensitive optical technique, Quartz Crystal 
Microbalance (QCM) measurements13 or microcantilever detectors14. A complete 
understanding of the different variation and technology used in immunoassay analysis can be 
found in the book of Diamandis and Christopoulos,  entitled Immunoassay15. 
 
2.4 Cancer 
2.4.1 Basics of Cancer 
Normally, every eukaryotic cell follows a standard protocol known as the cell cycle to divide 
into two, i.e. to reproduce. The divided cells join and organize into collaborative assemblies 
known as tissues. The cell cycle is promptly regulated and controlled by means of complex 
chemical signaling pathways based on various regulatory proteins. This control system 
continuously monitors and responds to the internal and external signals arising from inside the 
cells and from the other neighboring cells, respectively. Depending on the signals acquired 
from the other cells (e.g. cells in a tissue), each cell either lives divides or dies (apoptosis/self-
sacrifice) to support the total well-being of the tissue in which it resides. Thus, the cell-cycle 
control system forms the basis in regulating the number of cells in the body tissues. This clearly 
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shows that the cells are very social and they work in unison for a common goal.  However, 
certain cells can turn anti-social for a multitude of reasons (internal and/or external) and start to 
behave in an abnormal way. These cells, by evading the cell-cycle control systems, start to 
proliferate in a random manner and thereafter they slowly invade the space which is normally 
meant for normal cells. This abnormal proliferation and growth of some cells results in tumor 
and if the tumor is malignant then it is called a cancer. Exposure of somatic cells to carcinogens 
(e.g. X-ray, tobacco, viruses etc.) damages and alters its various DNA sequences, thus resulting 
in multiple mutations over time. This directly affects the cell-cycle resulting in the tumor 
growth. Fig. 2.10 depicts the anatomical and functional differences between a normal cell and a 
cancerous cell. Cancer cells have the ability to enter blood or lymphatic vessels, and form 
secondary tumors, called metastases, at other sites of the body. Metastases are normally the last 
stage in the cancer progression resulting in the death of the cancer patient. 
 
 
Figure 2.10. A schematic illustration of the differences between a normal cell and a cancerous 
cell. The irreversible changes in the cell DNA sequence, caused by mutations, translocations, 
deletions etc., directly results in the production of abnormal proteins which are called as 
cancer markers. Cancer markers can be found inside and outside the cell including on its 
membrane. As the fundamental cell-cyle governing DNA is damaged in a cancer cell, it induces 
erratic growth and abnormal reproduction, thus affecting the functioning of the normal cells 
surrounding them. (From reference16). 
 
 Chapter 2: Background 
21 
 
There are three main categories of cancers that occur in humans and they are based on the cell 
type from which they arise. They are carcinomas – cancers from epithelial cells (e.g. breast, 
lungs, oral cavity etc.), sarcomas – cancers from muscle cells and/or connective tissues and 
lymphomas – cancers from white blood cells and/or nerve cells. About 80% of human cancers 
are carcinomas as the epithelial tissues are most frequently exposed to the cancer causing 
agents or carcinogens17.  
2.4.2 Cancer diagnosis and therapy 
Cancer diagnosis starts with imaging the parts of the body having cancer-like symptoms. This 
is done using one of the standard clinical imaging techniques (e.g. Magnetic Resonance 
Imaging or MRI, endoscopy). Following this, biopsy of the irregular tissue is done for further 
investigation by pathologists. Biopsy is an invasive procedure that either removes fully or 
partially the tumor-like tissues or other relevant clinical samples either for cancer diagnosis or 
prognosis. In addition to this, the clinical samples like blood, urine etc. collected from the 
patient will also be tested for the presence of cancerous cells and as well as other cancer 
biomarkers (e.g. oncoproteins, oncogenes). Thanks to the advancements in the fields of 
proteomics and genomics, today it is possible to screen and profile thousands of cancer 
biomarkers in a rapid and automated manner. Based on the results obtained from the above 
mentioned clinical procedures the physician stages the cancer followed by its prognosis (See 
Fig. 2.11).  
 
Figure 2.11. To arrive at a valid and comprehensive decision on cancer prognosis and therapy 
an oncologist invariably requires inputs/results from a wide-range of, complementary, clinical 
and laboratory diagnostic tests. (From reference18) 
 
 Chapter 2: Background 
22 
 
For example, in diagnosing the breast cancer, as a first step, imaging of the breast using X-ray 
(mammography) would be done  and if the mammogram indicates some tumor-like locations 
then a biopsy will be carried out in those exact locations. The biopsied tissue (for example see 
Fig. 2.12), after fixation, will be sent to a pathologist who studies the organization of different 
cells, their shape, various genes and the proteins present or expressed in the cells by 
microscopic examination. To aid the clear visualization and classification of various cells the 
tissue is stained using standard staining procedures. Once the pathologist identifies the presence 
of malignant tumor cells he grades the cancer (staging) based on standardized TNM procedure 
where T describes the tumor size, N describes the involvement of lymph nodes and M stands 
for metastasis19. Based upon the test reports from pathologists and from the clinical samples 
indicating the presence and levels of various cancer markers, oncologists will perform 
prognosis as well as sub-classify the breast cancer. This sub-classification will enable them to 
decide the exact mode of therapy (targeted therapy or personalized medicine). For instance, the 
cancer markers oestrogen receptor (ER) and human epidermal growth factor receptor-2 
(HER2/neu) status in breast cancer have direct implications on deciding the outcome of the 
disease and therapy. If ER is positive then oestrogen hormone inhibiting drugs will be used for 
therapy whereas if HER2/neu is positive then the drug that specifically targets the same will be 
administered. 
 
 
 
Figure. 2.12. A representative optical micrograph, pertaining to a breast tissue-slice biopsied 
from a breast cancer patient and thereafter fixed in paraffin, shows the presence of cancerous 
cells (large and black) surrounded by normal cells (small and blue). (courtesy: Prof. A. Lehr, 
Department of Pathology, University Hospital Lausanne (CHUV)) 
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After starting the cancer therapy, the evolution has to be continuously assessed for further 
prognosis. This means that the patient might have to undergo the same set of procedures which 
were outlined above. However, biopsy being an invasive procedure, is time-consuming, and as 
well as inconvenient for a patient, if he or she has to undergo it too many times. Especially, if 
biopsy has to be conducted on important but not easily accessible organs e.g. the brain, then it 
has to be done with extreme care as otherwise it can risk the patient’s life. On the other hand 
conventional laboratory techniques for screening clinical samples not only require relatively 
large amount of clinical samples but they are also laborious, time-consuming and hence 
expensive. Though biopsied tissue investigation and conventional laboratory-based sample 
analysis methods will remain the preferred procedure for some years to come, in cancer 
prognosis, other emerging diagnostic methods like microfluidic chip technology have a great 
potential to complement the standard diagnostic procedures. Especially when it comes to early 
diagnosis, for monitoring the therapy outcome and helping to choose the type of therapy a 
patient has to undergo on a regular basis, lab-on-a-chip systems have a high potential. 
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3.1 Protein micropatterning methods 
Micro-patterning of proteins (e.g. Abs, fibronectin (FN) etc.) is a basic requirement for 
realizing bio-analysis chips or simply bio-chips. Bio-chips are used for performing 
immunoassays, high-throughput screening of proteins, drugs and for studying protein-protein 
interaction kinetics1, 2. In addition to this, protein arrays are used for cellomics applications 
which includes capturing, patterning and/or directing the growth of the desired cells in specific 
locations3, 4. This section provides a review of different methods that are available for protein 
micro-patterning on a bare substrate and in-situ inside a microfluidic channel, where the latter 
is of particular importance in realizing lab-on-a-chip diagnostic devices. For further reading on 
other bio-molecular patterning techniques we refer to the comprehensive review articles 
published elsewhere4-8. 
3.1.1 Pin-printing and inkjet printing 
Pin-printing 
Pin-printing is a widely used technique for the fabrication of DNA microarrays9, 10 and in recent 
years, this technique has been adapted for protein patterning2, 11, 12. In pin-printing a pin loaded 
with ink, i.e. a protein solution, is brought in contact with a pre-functionalized substrate. When 
the pin retracts from the surface, it leaves a nanoliter-droplet of the protein solution. In order to 
prevent the drying-out of the small droplets, the protein solution contains 40 % glycerol2. 
Following this, the droplet is incubated for a specified time allowing the proteins to chemically 
link to the pre-functionalized surface. Prior to washing of the excess protein solution, the 
remaining background surface is blocked with bovine serum albumin (BSA). The total pin-
printing process is automated and several companies are selling robotic printing machines. 
However, these machines are expensive and hence not suitable for research laboratories which 
are constantly looking for simple, cheaper and efficient alternatives. Also as the pin comes in 
contact with the substrate surface, the former suffers from constant wear thus affecting its life-
time and hence requiring maintenance and repair. 
Inkjet printing 
Inkjet printing was originally developed for printing inks on papers and later it has been 
adapted for printing proteins and other bio-molecules on various substrates13, 14. Ink-jet printing 
can be viewed as a cheap alternative to pin-printing. Also, unlike pin-printing it is a non-
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contact protein patterning approach. There are two inkjet printing techniques, one is thermal 
based and the other is piezoelectric based13, 14. A typical inkjet printer comprises of an ink-
reservoir with a nozzle and a mechanism i.e. a heating element or a piezo-device for effecting 
the printing by ejecting a defined volume (a droplet) of ink through the nozzle hole. 
Piezoelectric inkjeting is highly-preferable to the traditional heating-element based printing as 
high-temperature can directly affect the protein stability12, 13. The resolution of protein patterns 
is limited by the undesirable satellite droplets that are generated during the printing process and 
by the type of substrate used (hydrophobic/hydrophilic)15. Both printing techniques, i.e. pin and 
ink-jet printing, can achieve a pattern resolution down to 150 to 200 μm, which is relatively 
large when compared to other existing techniques. In addition to this, they often cause smearing 
of the proteins spots as shown in Fig. 3.116. 
 
 
 
Figure 3.1. A representative fluorescent micrograph showing spotted patterns of Alexa-546 
labeled streptavidin, on a biotin-coated surface, smeared after washing. (From reference 16) 
 
3.1.2 Microcontact printing 
Microcontact printing (mcp), which was invented by the Whitesides group17 in 1993, has fastly 
emerged as one of the commonly used laboratory techniques for protein micropatterning due to 
its simplicity and cost-effectiveness. With this technique, even sub-micron features of proteins 
can be realized. The principle of mcp is illustrated in the Fig. 3.2 and it is very similar to the 
stamping process used for stamping office-seals. Three things that are essential for 
microstamping or mcp is (1) a stamp made of an elastomer, (2) ink for pattern transfer and (3) a 
substrate on which the pattern has to be stamped or created. The microstamps are often realized 
using a silicone-based elastomeric material known as poly(di-methyl siloxane) (PDMS). PDMS 
has emerged as the most popular material for not only making stamps but also for realizing 
microfluidic devices and structures - because it is inexpensive, transparent to the visible light, 
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can easily adsorb biomolecules on its surface and can be processed in a non-clean room i.e. in a 
conventional laboratory environment4. 
 
 
 
Figure 3.2. Schematic illustration of the steps involved in microcontact printing of proteins. 
The elastomeric stamp surface is incubated or inked with a protein solution (a) and then briefly 
dried gently under a nitrogen stream for few seconds (b). Thereafter the inked-stamp is brought 
in contact with the substrate (c), thus resulting in the protein micropatterns (d). 
 
PDMS stamps as well as other PDMS microstructures (e.g. microfluidic channels) are 
replicated by means of a soft-lithographic route which is known as the micro-molding 
technique (see Fig 3.3)18, 19. The basis of the micro-molding technique is a master wafer having 
micropatterns for replication in PDMS. The master itself is usually realized with a single 
photolithography step in a clean-room. 
 
 
 
Figure 3.3. Soft-lithography route for PDMS stamp micromolding. The master is fabricated 
using standard photolithography using SU-8 photoresist (a) and then PDMS is poured and 
cured (b) and finally the cured PDMS replica is peeled-off from the mold (c). 
 
Mcp was originally developed as a simple alternative for realzing etch masks in a laboratory 
environment. Kumar et al.17 demonstrated the mcp of alkanethiol self-assembled monolayer on 
gold thin-films, where the former were used as mask for microstructuring the latter by 
selectively etching the exposed gold areas. Extending on the idea of Kumar et al., later Singhvi 
et al.20 showed that the micro contact printed alkanethiol micropatterns can be used for 
selectively adsorbing proteins, thus generating/realizing protein micropatterns in an indirect 
manner. The group of Delamarche21, 22 demonstrated the direct patterning of proteins, in a 
single step, on glass and silicon substrates using PDMS microstamps. Regardless of direct or 
indirect protein patterning, the PDMS stamps have to be inked with a desired molecule solution 
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(e.g. alkanethiols, DNA, proteins etc.) and thereafter briefly dried before stamping on a 
substrate. Mcp of proteins has been demonstrated on a variety of substrates viz. silicon22, 
glass22, mica23, self-assembled monolayer (SAM) coated surfaces24, Poly(methyl methacrylate) 
or PMMA25 etc.. As an example, Fig. 3.4 shows an array of immunoglobulin G stamped on a 
silicon substrate using PDMS stamps. In other work, microcontact printing was used as the 
basis for micropatterning of streptavidin-coated magnetic beads26. First biotinylated-BSA was 
microcontact printed on a glass substrate and thereafter biotin-streptavdin chemistry was used 
to chemically self-assemble the beads on biotin-BSA micropatterns. 
 
 
 
Figure 3.4. Representative atomic force micrographs showing a microcontact-printed array of 
IgG on a silicon substrate (left) and a zoomed image of a single protein pattern (right), 
respectively. (From reference22)  
 
Though mcp is simple and the fabrication of PDMS stamps is inexpensive, the inking process 
itself requires a relatively large volume of inks i.e. protein solutions for finally transferring just 
a monolayer of the same on a surface. In addition to this, optimization of the microcontact 
printing process is complex as it depends on a multitude of parameters like the stamp’s 
mechanical property, stamping pressure, the micropattern features, type of substrate and its 
surface-pretreatment, the method of inking the stamps, ambient humidity and last but not least 
the expertise of the process engineer/researcher. Also after mcp, the once-used stamps require a 
thorough cleaning before re-use and quite often the cleaning of physically adsorbed proteins 
from the PDMS surface is cumbersome. Despite the fact that the mcp has been reported as a 
tool for creating high-resolution protein micropatterns, the repeatability and pattern fidelity of 
the microcontact printed protein patterns depend on a complex set of parameters, like the 
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mechanical behavior of the PDMS stamps, the type of surface and the forces acting between the 
stamp and substrate surface, the pitch between the adjacent pattern-features, the height of 
patterns and the load applied while stamping.27, 28 
3.1.3 Parallel microfluidic channels 
Parallel microfluidic channels, formed by reversibly sealing a PDMS replica, having an array 
of microchannels, with a substrate, have been used as a template for patterning of proteins29. 
The protein solution is filled inside the channels through capillary forces and then incubated for 
a while resulting in the adsorption of the protein molecules on the substrate surface. 
Subsequently the excess protein solution is washed-off in buffer and the guiding PDMS replica 
is removed from the substrate leaving the protein patterns. Though this method is simple, due 
to the restriction posed by the channel geometry, only a straight or curved line-array of protein 
patterns can be realized based on this approach. 
3.1.4 Lift-off and stencil-assisted methods 
The lift-off technique was originally developed as an alternative but yet a simple approach to 
structure metal thin films deposited by evaporation30. During the last decade, this approach has 
been extended for patterning organic thin-films and a monolayer of molecules deposited via 
different techniques, viz. plasma enhanced chemical vapor deposition, spin-coating, self-
assembly, physical or chemical adsorption etc.. The lift-off process is schematically illustrated 
in Fig. 3.5a. First a photoresist layer is spin-coated on a substrate and thereafter patterned by 
photolithography. Following this a thin-film or a monolayer of the desired material/molecule is 
deposited on the substrate. Thereafter the thin-film on top of the resist areas is selectively lifted-
off chemically in a solvent resulting in micro-patterns of the deposited material/molecule. Lift-
off based protein patterning was first demonstrated by Bhatia et al.31 in which they patterned 
collagen I, a cell-adhesion promoting protein. They directly immobilized collagen-I on the 
resist-patterned substrate and then performed lift-off in acetone.  
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Figure 3.5. Schematic illustration of protein patterning (a) using the lift-off technique and (b) 
with a micro-stencil. (a) In the lift-off technique, a spin-coated photoresist layer (i) is 
structured using standard photolithography (ii). Then a desired protein solution is incubated 
on the substrate resulting in the chemical/physical adsorption of the proteins on top of the 
resist and the exposed substrate regions (iii). Finally, the resist is selectively dissolved in a 
solvent resulting in the protein patterns as in (iv). (b) In the stencil-based approach, a shadow 
mask is brought in close contact with the substrate (i) and then the protein solution is incubated 
on top of this stencil-substrate assembly (ii). As a final step, the stencil is separated from the 
substrate resulting in the protein micropatterns (iii). 
 
Acetone can easily denaturate the proteins as they are known to attack all organic substances. 
However, they reported that the proteins where “sufficiently” intact, even after being exposed 
to acetone, as evidenced by the cell adhesion and growth in their work. However, for 
immunoassay and drug discovery applications, it is important to maintain the structure of 
patterned Abs as intact as possible, as otherwise it can impair their proper functioning to a large 
extent. In other work, the group of Textor et al.16, 32 electrostatically adsorbed a protein 
copolymer (Polylysine-g-Polyethylene glycol) on a pre-patterned glass substrate followed by 
lift-off using N-methlyl-2-pyrrolidone, a protein-friendly peptide processing solvent, instead of 
acetone for photoresist removal. Then they used the biotin-streptavidin combinatorial chemistry 
to create streptavidin micropatterns. Lee et al.33, 34 demonstrated an indirect approach to pattern 
proteins via the lift-off method. They first patterned a hydrophobic Teflon-like layer, formed by 
spin-coating on a pre-patterned glass substrate, by lift-off and thereafter used this as a template 
to covalently immobilize proteins only on the Teflon-free, exposed glass areas. However, this 
approach is suitable only for less-hydrophobic proteins as otherwise they can physically adsorb 
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on the hydrophobic Teflon background resulting in a huge background noise during analysis 
and measurements. Craighead et al.35 demonstrated a dry lift-off process by using a 
micropatterned parylene-C layer. The parylene-C layer was deposited via spin-coating and 
following this, using a photoresist mask, the former was micropatterned through dry etching 
under oxygen plasma. After stripping of the photoresist, the micropatterned parylene-C was 
used as a mask for selectively depositing a desired protein on the exposed glass areas. After 
protein deposition, the parylene-C mask was mechanically peeled-off resulting in protein 
micro-patterns on a glass substrate, thanks to the generally weak adhesion of parylene-C on 
many materials. This method clearly overcomes the limitations of wet-etching i.e. the demerits 
of protein exposure to organic solvents. 
 
Micro-stencils, also known as shadow-masks, have recently emerged as a potential alternative 
for patterning nontraditional materials whose processing is not straight-forward or not easy 
using conventional clean-room methods36. Later on, it has been adapted as a simple alternative 
for even patterning traditional materials, especially on topographically non-planar substrates 
(e.g. pre-structured substrates) in a ‘dry’ manner37, 38. Here the term ‘dry’ means that, unlike the 
lift-off technique, this process does not require solvents or wet-etchants for creating the 
micropatterns. Though stencils can be realized on a variety of materials (e.g. silicon, metals, 
silicon nitride, polymer etc,), polymer stencils are very attractive, especially for patterning bio-
molecules, as they are flexible, pin-hole free, can be structured using plasma-etching, and most 
of all bio-compatible. The method of patterning proteins using stencils is illustrated in Fig. 3.5b 
Stencil-based protein patterning was first demonstrated using a PDMS-sieve by the Atusta 
group39. As PDMS is an elastomer, it can be sealed against any substrate by briefly treating it 
with oxygen plasma, however creating a high-resolution PDMS-based stencil is cumbersome. 
After the Craighead group demonstrated the use of parylene-C in protein patterning, it has 
emerged as one of the preferred materials for fabricating micro-stencils40, 41. Recently, 
parylene-C based stencils have been successfully employed for protein-patterning even on 
curved surfaces by Selavarasah et al.42. 
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3.1.5 In-situ protein patterning inside microfluidic channels 
As discussed before, though there are several methods available for protein micropatterning on 
a given substrate, they are not suitable for realizing protein micropatterns in-situ inside a sealed 
microfluidic channel. Though it is possible to realize a microfluidic bio-chip by reversibly 
sealing a protein-coated substrate against another substrate with a microchannel relief (e.g. 
PDMS replica), however, this sealing step has to be done under dry conditions which can be 
harsh to the proteins thus resulting in their denaturation. Few groups have demonstrated the 
patterning of proteins directly inside a packed microfluidic channel based on different 
approaches which are discussed below. 
 
 
 
Figure 3.6. (a) Schematic illustration of laminar-flow-assisted patterning of proteins in-situ 
inside a microfluidic channel. (b) This fluorescent micrograph shows two fluorescent lanes, 
along the edges of a microfluidic channel, in which fluorescent-BSA is selectively 
deposited/patterned using laminar flow43. 
 
In 1999, the group of Whitesides first demonstrated the possibility to pattern proteins inside a 
microfluidic channel by means of laminar flow44. For this they used a microfluidic network, 
fabricated in PDMS, as schematically shown in Fig 3.6a, and having three inlets which 
converged to a common channel. Using fluorescently-labeled BSA and bare BSA as model 
proteins, they demonstrated the patterning of the former along the edges of the channel and the 
latter in the mid-way of the same channel. This was possible by simultaneously flowing the 
fluorescently-labeled BSA and bare BSA solutions through the two exterior inlets (inlet 1 and 
3) and the central inlet (inlet 2), respectively, as shown in Fig. 3.6a. Thanks to the laminar flow, 
the fluorescent-labeled BSA proteins adsorbed only along the edges of the channel which was 
evidenced by the fluorescence detection (see Fig 3.6b). By having ‘n’ inlets, simultaneous 
patterning of ‘n’ different proteins inside a single channel is possible. In 2004, Holden et al.45 
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demonstrated a generic approach for patterning of proteins, inside a microfluidic channel under 
exclusively aqueous conditions, based on the combination of photo-activable chemistry and 
biotin-streptavidin combinatorial chemistry. Their approach is illustrated in the schematic 
shown in Fig. 3.7a. First they passivated the microfluidic channel walls by coating with a 
fibrinogen monolayer followed by the photo-activated (laser-induced), selective attachment of 
fluorescein-labeled-biotin molecules on the areas activated by shining a laser beam (488 nm). 
Following this, they created streptavidin micropatterns using biotin-streptavidin affinity. In 
2006, Park et al.46 reported an electrical-signal guided method for assembling charged proteins, 
at electrically addressable locations, in situ inside a microfluidic channel. Their microfluidic 
device consisted of patches of addressable gold electrodes, as shown in Fig. 3.7b which, when 
activated by applying a negative-potential, resulted in the assembly of the positively-charged 
biomolecules. They first deposited chitosan molecules, which are rich in amine groups and 
hence positive charges, by activation of the electrodes. Following this, the chitosan monolayer 
was activated with glutaraldehyde linker and, forming the base for covalently-linking any 
desired protein. 
 
 
 
Figure 3.7. Schematic illustration of protein-patterning in-situ inside a microfluidic channel (a) 
using photo-attachment chemistry45 and (b) using electrostatic forces generated by integrated 
electrodes46. 
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Figure 3.8. (a) Schematic illustration of the concept of micropatterning of protein-
functionalized magnetic beads inside a packaged microfluidic chip using laminar-flow and 
magnetized integrated nickel stripes (i) and an optical micrograph showing a part of the 
microfluidic channel in which the beads are self-assembled and retained in front of the 
magnetized nickel stripe-tips (ii) (From reference47). (b) Schematic illustration of the concept 
of magnetic bead self-assembly using a microchannel with a periodically varying microchannel 
cross-section (i) and an optical micrograph showing the streptavidin coated beads that are 
retained along the large sections under a uniform magnetic field (ii) (From reference48, 49). 
 
As an alternative to the above discussed methods, the use of magnetic beads as a platform for 
bio-analysis and chemical-analysis in lab-on-a-chip systems is rapidly growing. The advantages 
of the magnetic beads have been clearly discussed in Chapter 2 under section 2.1. Magnetic 
bead-based on-chip protein patterning has been demonstrated by the Hansen group47 and by the 
Gijs group48-50. In both works, protein-functionalized magnetic beads, that are commercially 
available, were introduced inside a microfluidic channel and thereafter the former was 
immobilized using external magnetic fields. In the work of Smistrup et al.47, electroplated 
nickel micro-stripes (see Fig. 3.8a), that were present on either sides of a microchannel, were 
used for focusing the external magnetic field originating from permanent magnets.  The 
magnetized nickel stripes acted as a template for locally immobilizing the beads thus resulting 
in the micropatterns of the latter. They used laminar flow to demonstrate the simultaneous 
patterning of two differently functionalized beads by flowing the two types of beads separated 
by a buffer flow in the middle. Using this method the number of beads that can be immobilized 
per Ni-stripe tip can be well controlled, based on the magnetic field intensity, flow velocity and 
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the density of the beads, However, their chip fabrication involves several clean-room 
processing steps including silicon dry etching and nickel electroplating and this is expensive for 
realizing a single time use-and-throw bio-analysis chips. In the work reported by Lacharme48-50 
et al., the retention of streptavidin-coated magnetic beads in a microfluidic channel was 
achieved by periodically varying the width of the channel. When brought into a homogeneous 
magnetic field applied perpendicular to the channel axis, a solution of magnetic beads flowing 
through the microchannel spontaneously self-assembled into an array of magnetic chains 
located at the enlarged cross-sections of the microchannel (see Fig. 3.8b). This configuration 
benefits from the lowest total magnetostatic energy, as originating from magnetic dipole 
interactions between the individual magnetic beads. There are other reports that show the 
immobilization of protein coated magnetic beads using external magnetic fileds51-56. However, 
rather than creating ordered bead-patterns they were based on a cluster or plug of beads. As a 
result, the number of beads in the cluster can vary from one experiment to the other depending 
on the various parameters involved. 
3.1.6 Conclusion 
Different protein patterning methods were discussed in this review section, which covers the 
traditional methods for protein patterning on a bare substrate and modern methods used for in-
situ protein patterning inside a microfluidic channel. Also, the merits and demerits of the 
discussed methods are high-lighted. As presented here, for on-chip bio-analysis, commercially 
available protein-coated magnetic beads have emerged as a preferred analysis platform. As a 
simple alternative to the existing bead-based protein patterning methods, in chapter 4, we 
present a novel and versatile method for the precise micro-patterning of protein-coated beads 
using electrostatic self-assembly. Our method is suitable for patterning protein-coated beads 
either on a bare substrate surface or inside a sealed microfluidic channel. 
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3.2 Bead-based microfluidic immunoassays 
As discussed in chapter 2, after the introduction of the soft-lithography techniques by the 
Whitesides group, the fabrication of microfluidic channels became inexpensive and facile for 
the microfluidics and lab-on-a-chip community. As a result, there was a quantum jump in the 
application of microfluidics for biology and more notably for proteomics and cellomics 
applications. The concept of microfluidic sandwich immunoassays forms the back-bone of 
portable diagnostic systems. The first microfluidic sandwich immunoassay was reported by the 
group of Delamarche in 2001 using parallel microfluidic channels realized in PDMS57. In this 
work they demonstrated the detection and quantification of mammalian IgG’s (Goat, rabbit 
etc.) using fluorescence detection. In 2004, the same group demonstrated the detection of a 
clinically relevant bio-marker Tumor Necrosis Factor-alpha (TNF-α) for auto-immune 
disease58. Both the above reports involved surface-based microfluidic immunoassays, i.e. the 
microchannel surface that was coated with the capture antibodies was used as the basis of Ag 
capture. Many other surface-based microfluidic immunoassays have been reported elsewhere59-
66
. 
 
In the past years, microfluidic bead-based immunoassays have emerged as a potential 
alternative to the surface-based microfluidic immunoassays. As mentioned in Chapter 2, the 
functionalized beads in general and magnetic beads in particular offer multiple advantages 
when they are combined with microfluidics67-71. The fundamental main bottle-neck step in the 
case of surface-based immunoassays is the tailoring of the microchannel surface-chemistry for 
allowing a reproducible coating of capture Abs. This drawback is circumvented by using 
protein-functionalized magnetic beads which are tailor-made and commercially available. Also, 
using localized magnetic fields, magnetic beads can be confined and retained within a small 
volume inside a microfluidic channel, which forms the basis for the localized capture and 
concentration of target Ags on a bead plug, thus resulting in a enhanced signal sensitivity. 
Finally, the magnetic beads can be easily recovered after analysis for further down-stream 
applications or off-chip analysis. This section high-lights the work that uses magnetic beads as 
the solid-phase for the immuno-complex formation, followed by detecting the target Ags using 
one of the conventional detection methods viz. fluorescence, electrochemical and optical  
microscopy. For a comprehensive reading on this topic readers are referred to the recent review 
article from Gijs et al69.  
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Figure 3.9. (a) Schematic illustration of the concept of magnetic bead capture inside a 
microfluidic channel using an external permanent magnet (b) Optical micrograph of a part of a 
packed bed of 1-2 μm diameter magnetic particles within a 50-μm diameter fused silica 
capillary in the presence of a 0.236 T magnetic field. (c) Calibration curve for interleukin-5 
(IL-5) generated from a sandwich immunoassay performed on the magnetic particles retained 
inside the capillary tube as shown in a-b. (From reference 51) 
 
3.2.1 Fluorescence-based detection 
Fluorescence-based detection is so far the main method for conventional as well as modern lab-
on-a-chip immunoassays. This can be attributed to its high-sensitivity and also the commercial 
availability of robust fluorescent dyes with emission at distinctly different wavelengths. Hayes 
et al.51 demonstrated a bead-based microfluidic immunoassay using a plug of 1-2 μm sized 
magnetic beads captured inside a micro-capillary. First, the plug was formed by placing a 
strong rare-earth disc magnet over the microchannel and thereafter the beads were exposed to 
the flow of appropriate reagent and analyte solutions (see Fig. 3.9). They demonstrated a direct 
assay for detecting Fluorescein isothiocyanate (FITC) using a plug of anti-FITC-coated beads 
and also presented complete sandwich immunoassays for the calibration of parathyroid 
hormone and interleukin-5 down to a few ng/ml. Herrmann et al. demonstrated on-chip enzyme 
linked immunosorbent assays (ELISA) using magnetic beads that were retained using external 
permanent magnets52-54. Their experiments were performed in parallel PDMS-based 
microfluidic channels and under stop-flow conditions. In their initial work, which was 
presented in 2006, all the assay steps were executed off-chip but the final detection step i.e. the 
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enzyme-substrate reaction for fluorescence signal amplification was performed on-chip53. For 
this, beads with immuno-complexes formed off-chip were injected inside the microfluidic 
channel and then trapped using a permanent magnet. Subsequently, the substrate solution was 
introduced inside the channel and the trapped beads were used as an active mixer, by 
magnetically moving them back and forth along the channel direction, for speeding up the 
enzyme-substrate reaction and for homogenous spreading of the generated fluorescence signal 
throughout the channel. In this, they used anti-streptavidin IgG as a model Ag and they were 
able to detect the same down to 12.5 pg/ml using ~10 μl sample. In 2007, the same authors, 
building upon their past work, reported a full on-chip immunoassay. 
 
 
Figure 3.10. (a-d) Schematic illustration of the concept of magnetic bead-based immunoassay 
in a dual-network channel. (a) A magnetic bead plug is introduced inside the immuno-reaction 
chamber in which the former is incubated and mixed with different reagent and washing 
solutions resulting in the formation of immuno-complexes and, (b) Thereafter the bead plug is 
moved to the detection chamber by opening the bridge valve. (c) In the detection chamber the 
bead plug is mixed with the substrate solution resulting in the enzyme-substrate reaction. (d) 
The resultant solution is moved to one side of detection chamber for fluorescent detection. The 
four color micrographs in the middle (between the images (a-d) and (e-f)) show the magnetic 
plug actuation sequence in a PDMS dual-network channel and the schematic in the bottom is a 
pictorial representation of the immuno-complex formed on the bead surface and the 
fluorescence signal emanating from the enzyme substrate reaction. (e) and (f) Fluorescent 
micrographs showing the immunoassay results from the immunoassays performed in a single 
channel network and a dual channel network, respectively. It can be observed from the images 
(e) and (f) that the noise is substantially lower in the case of dual network approach when 
compared with single network approach. (From reference 52) 
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The heart of their second-generation system is a dual-channel network52, separated by means of 
a pneumatic PDMS-membrane valve72, in which one channel was used for immuno-complex 
formation and the other for performing detection (Fig 3.10a-d). After closing the valve, the 
beads were injected in the first channel in which they were trapped and thereafter immuno-
complexes were formed by exposing and incubating the former with the Ag and capture Ab 
solutions in the same sequence. Thereafter, after opening the valve, the beads were moved into 
the second channel using magnetic forces and thereafter the enzymatic reaction and detection 
was performed. As the immuno-complex formation phase is completely separated from the 
detection phase, the signal-to-noise ratio is greatly enhanced in the case of dual-network based 
immunoassays, when compared with their single-network format by avoiding the noise that is 
generated by the non-specifically adsorbed proteins during the former (immune-complex 
formation) step (see Fig 3.10e-f). Recently, the same authors used the dual-network system for 
the quantification of TNF-α in serum and cell-culture medium. They were able to detect TNF-α 
concentrations down to 45 pg/ml54. In 2008, Lacharme et al.48-50 demonstrated a full on-chip 
immunoassay, using only a few nanoliters of sample solution, based on an array of self-
assembled magnetic bead chains. The magnetic chain formation and retention was made 
possible through a periodically enlarged microchannel cross-section combined with the 
application of an uniform magnetic field perpendicular to the channel direction. A 1 ng/mL 
detection limit was obtained for mouse IgG. The assay was executed either completely on-chip 
while consuming nano-liter volume of sample and reagents48, 50, or part of the protocol was 
performed off-chip49. Liu et al.73 demonstrated a full microfluidic immunoassay using magnetic 
beads retained with two external mini-solenoids assembled at a close proximity on either side 
of a microfluidic channel. When compared to permanent magnets, microsolenoids provide the 
possibility to apply a more spatially localized magnetic field on demand, i.e. the latter can be 
switched-on and-off based on the requirements and, compared to integrated electromagnets, the 
fabrication of the microsolenoids is easier and less expensive. They were able to detect goat 
IgG down to ~ 5 ng/ml from a 500 nL sample volume. Instead of retaining the beads and 
keeping them as a static phase for immuno-complex formation, the group of Pamme 
demonstrated a direct streptavidin-biotin assay under continuous flow by dynamically 
maneuvering streptavidin-coated magnetic beads across the co-laminar streams of fluorescently 
labeled biotin (reagent) and buffer (washing) solutions74. Recently, the same group 
demonstrated the simultaneous detection of multiple Ags from a single sample solution using 
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three plugs of beads coated with different Abs55. The bead plugs were magnetically retained in 
a periodic fashion inside a single microfluidic channel. In other work, a monolithic and fully-
integrated Complementary Metal Oxide Semiconductor (CMOS) chip was presented for the 
manipulation and detection of single fluorescent magnetic beads in a PDMS microchannel 
positioned on top of the chip75.  Magnetic manipulation was done by current actuation of 
microcoils on the silicon chip and detection was achieved using single photon avalanche diodes 
that were located in the centre of each microcoil and count the fluorescent photons originating 
from a single magnetic bead75, 76. This approach permitted microscope-less fluorescence 
detection with high sensitivity. Detection of murine monoclonal Abs with a limit of 600 pg/mL 
was reported in a sandwich immunoassay, performed using the bead surface as assay substrate. 
3.2.2 Electrochemical/Amperometric detection 
The group of Ahn presented a fully integrated microfluidic electrochemical (amperometric) 
immunosensor based on magnetic beads77. The bottom substrate of the immuno-reaction 
chamber comprised an electromagnet and the top cover had the inter-digitated electrodes for 
electrochemical detection and quantification of the target Ags (See Fig 3.11a-b). First they 
retained the anti-mouse IgG coated magnetic beads by switching-on the electromagnet and 
subsequently they built the immuno-complex by exposing the beads to the Ag solution (mouse 
IgG) and p-aminophenyl phosphate (PAPP) enzyme-labeled detection Abs. Thereafter PAPP 
was incubated with p-aminophenol (PAP) substrate molecules resulting in an electrochemical 
product, proportional to the amount of captured antigens. which is sensed using integrated 
electrodes as a change in the current signal (See Fig 3.11h-i). Using their system, the authors 
were able to detect mouse IgG down to a concentration of ~ 50 ng/mL using a sample volume 
of ~ 10 μL. Recently the same group reported a slightly modified version of their previous 
system in which they used permanent magnets and electroplated nickel (Ni) pillars for the 
bead-capture78. As Ni pillars focuses the magnetic fields, a high magnetic force is possible 
using this bead-retention method when compared to the method based on planar electromagnet. 
Another elegant example of a magnetic-bead based portable immunoassay system is the 
GraviTM-chip79. This is an automated portable device, which uses the electrochemical sensing 
method for the target Ag detection. Gravi-chip uses an array of external magnets for not only 
spatially immobilizing the protein-coated beads but also for bringing them in close proximity to 
the detection electrodes thus enhancing the signal sensitivity and the response-time. Almost all 
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of the immunoassay microsystems reported so-far use an active-pump (e.g. syringe pump) to 
drive-in the reagents and analyte solutions inside the microfluidic channel, except the works of 
Lacharme et al.48 and Rossier et al.79; in the former work, flow is generated/established using 
surface tension forces and in the latter work it is through gravity and capillary forces. 
 
 
 
Figure 3.11. (a-g) Schematic illustration of the immuno-complex formation and detection using 
antibody-coated magnetic beads retained with an on-chip planar electromagnet and 
electrochemical sensor, respectively. (h) The graph showing the response curve of the 
integrated electrochemical sensor as a function of the concentration of electrochemical product 
(PAP) generated from the enzyme-substrate reaction and (i) Immunoassay results based on the 
amperometric detection for different antigen concentrations. (From reference 77)  
 
3.2.3 Optical-detection of immuno-agglomerates of beads 
In 2005, the first magnetic bead-based on-chip agglutination assay was demonstrated by the 
Tabeling group80. For proof-of-principle demonstration, they used magnetically retained 
streptavidin-coated magnetic beads as solid phase and biotinylated protein A as the target Ag 
which induced the agglomeration of the former. Their first experiments showed a limit of 
detection down to few pg/mL. This high sensitivity can be attributed to the easy perfusion of 
analyte through a loosely packed plug of magnetic particles in a microchannel. A very recent 
work from our group presented the dynamic actuation of a confined plug of functionalized 
magnetic beads in a microchannel allowing for analyte capture with improved efficiency56. 
Here a novel detection method based on the diffusion of the particle plug has been presented 
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(see Fig. 3.12). The feasibility of an on-chip agglutination assay is demonstrated by means of 
the streptavidin/biotinylated-BSA model system. A detection limit of 100 pg/mL has been 
reported. 
 
 
 
Figure 3.12. Detection and quantification of an Ag concentration based on the swelling of the 
streptavidin-coated magnetic bead-plug after switching-off the magnetic field. The optical 
micrographs, which were acquired 15 s after the immuno-agglutination assay, show the radial 
distribution of the magnetic particle agglomerates that were formed by exposing the initial 
bead-plug to a continuous flow of biotinylated-BSA solution of concentrations 0 ng/ml (a) and 
2.5 ng/ml (b), respectively. The radial distribution area is a measure for the analyte 
concentration. (From reference 56) 
 
3.2.4 Conclusion 
In a nut-shell, functionalized magnetic beads have fastly emerged as an important solution and 
platform for quantitative microfluidic immunoassays, thanks to the former’s wide commercial 
availability and inherent super-paramagnetic nature. The work that has been reviewed in this 
section, invariably is based on, immobilizing the beads in the form of a plug or several plugs 
inside a microchannel using magnetic field gradients generated by permanent magnets or 
electro-magnets, followed by immuno-complex formation on the retained bead surface. Though 
retaining magnetic beads in a plug that is freely suspended in a flow enhances sample 
perfusion, immobilization of beads in an array format, at very specific fixed locations, offers 
advantages. Localized surface-immobilization of beads would lead to a good control on the 
number of beads used in the assay and to an easy observation and analysis of the 
immunoreactions. Unlike the case of bead plugs, only few beads can be immobilized and 
exposed to the very small sample volume (few hundred nL) thus directly leading to purification 
and the concentrated capture of the analyte molecules by a few beads, thus resulting in an 
enhanced detection sensitivity. Additionally, bead-based protein arrays can open doors for 
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high-throughput screening of multiple analytes from a single sample. In chapter 5 we 
demonstrate on-chip immunoassays, using electrostatically self-assembled bead-arrays, for the 
detection and quantification of both single and multiple Ags from different model samples. 
3.3 Microfluidics based cancer diagnosis and prognosis 
A review of the recent literature shows that the microfluidic chips have been applied in cancer 
diagnosis and prognosis based on one of the two following methods: 
• separation and analysis of circulating tumor cells (CTCs) 
• quantification of cancer bio-markers present in the blood serum 
The capture and analysis of CTCs as well as the cancer bio-markers present in the blood from 
cancer patients is an important clinical step for non-invasively ascertaining the state and stage 
of the cancer, to choose the best mode of therapy and to frequently monitor the therapy 
outcome. In the following sections an overview of work taken from the recent literature is 
presented showing the application of microfluidic chips in cancer diagnostics. 
3.3.1 Microfluidic chip based cancer cells separation 
Out of different methods used for cell separation, an immuno-affinity-based method is the most 
preferred one for target cell separation in a microfluidic chip. Several reviews exist on on-chip 
separation and analysis of specific cells from a complex matrix. Different techniques which are 
used for sorting cancer cells and in general to enrich one cell type from a complex sample, can 
be grouped into one of the four following categories: 
• Fluorescence activated cell sorting (FACS) 
• Immunomagnetic cell separation (commercially known as magnetic activated cell 
sorting or MACS) 
• Cell physical parameters (size, dielectric property, mass etc.) based separation 
• Cell affinity chromotagraphy or immunoaffinity based cell separation 
Out of this, FACS 81 and immunomagnetic cell separation 82, 83 techniques have been widely 
embraced by both academia and industry due to their high-throughput and efficiency. Both of 
these techniques have been recently reviewed by Gijs et al.69 and the following paragraph is 
based on and adapted from the same reference. 
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Figure 3.13. (a) Schematic diagram illustrating the concept of FACS on a microfluidic chip. 
The cell solution is focused to the center of the microchannel using laminar-flow assisted flow 
focusing. The separation is done by deviation of specific fluorescently labeled cells (green in 
the picture) using optical forces. (b) An exploded view of the components which are part of a 
microfluidic FACS. The operation of this system requires expensive optical components 
including infra-red and 488 nm laser sources along with complex control electronics. (From 
reference 84) 
 
FACS instruments operate in the continuous-flow mode and use laser-induced fluorescence to 
count and direct droplet-based cells stained with fluorophore-conjugated Abs against an 
appropriate receptor present on the cell surface. As immunofluorescence is used as the 
triggering signal or readout, cells need to be labeled with fluorescent markers, which adds up to 
the cost. Also, immunofluorescence imaging requires higher quality optics, excitation sources 
and cameras than normal optical detection. FACS is expensive, voluminous and requires 
dedicated and trained staff to operate, but is a high-throughput technique, as up to about a 
million cells per second can be characterized and separated. In 2005, Wang et al. 84 
demonstrated the sorting of green-fluorescent-protein expressing HeLa cells (cervical cancer 
cells) using a microfluidic FACS chip (see Fig. 3.13) and they reported a recovery rate of >85 
% and a sorting rate of 100 cells/s. But the technique still requires high-quality and expensive 
detection optics and electronics. Though FACS can separate the cells from a continuous flow, it  
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Figure 3.14. (A) Schematic representation of the experimental protocol for immunomagnetic 
cell capture and sorting. (a) The channel was initially filled with a suspension of 
superparamagnetic beads. (b) The external magnetic field was applied, and the beads were 
trapped by the Ni micropillars. (c) Flow of buffer solution, which activates carboxyl groups on 
the surface of the beads and washes out any untrapped beads simultaneously. (d) Protein 
solution was then introduced into the flow stream. (e) Proteins were attached to the beads, and 
any unbound protein was washed out of the channel. (f) Cells were introduced into the channel. 
(g) Cancer cells were captured by specific protein-functionalized beads anchored to the nickel 
micropillars. (h) The cancer cells captured by the beads were eluted from the channel, when 
the external magnetic field was removed. (B) Covalent attachment of specific proteins to a 
magnetic bead and its capturing of a cancer cell. (From reference 85) 
 
does not allow the retention of the target cells in the microfluidic chip. Retention of the 
separated target cells inside a microfluidic chip can enable cell-culture and analysis 86-88. This 
explains the interest to look for alternative separation methods. In the immunomagnetic 
separation technique, cells labeled with superparamagnetic nanoparticles are retained in a high-
gradient magnetic field generated by placing a magnetic column in the field of external 
magnets 85, 89, 90. Then the column is removed from the separator and the retained cells are 
eluted. Subsequent cell detection is done using flow cytometry or microscopy. Selectivity of 
the separation is obtained by grafting the magnetic nanoparticles with antibodies against cell 
proteins on the surface of specific cells. The immunomagnetic method of cell sorting is less 
expensive and simpler than FACS, but it is important to note that this technique represents only 
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a first sample handling step before additional analysis. Therefore, the idea of performing 
magnetic separations on a microfluidic platform is attractive, as this will facilitate the 
separation, retention and counting of the cells on a single chip. Technical advantages such as 
the ability to create large magnetic field gradients using only modest magnetic sources and the 
capability for precise handling of the separated cells make the use of microscale magnetic 
sorters a very attractive option for point-of-care diagnostic devices. Microfluidic devices have 
been proposed to separate rare cancer cells from a blood sample based on immunomagnetic 
labeling. Human cervical cancer cells (HeLa) were internally labeled with magnetic 
nanoparticles following the endocytosis pathway and fluorescence was obtained by 
concomitantly labeling with rhodamine albumin 91. First the magnetic particle uptake by the 
cells over different incubation periods was studied. Cell populations were subsequently sorted 
according to their acquired magnetic moment using a free-flow microfluidic magnetophoresis 
device. Another type of integrated microfluidic device consisting of nickel micropillars, 
microvalves and microchannels was developed for specific capture and sorting of cancer cells 
85
. A regular hexagonal array of micropillars was integrated on the bottom of a microchannel. 
The Ni generated a strong induced magnetic field gradient in the presence of an external 
magnetic field to efficiently trap superparamagnetic beads from a flowing stream. These beads 
were first in situ bio-functionalized by covalent attachment of specific proteins directly to their 
surface. Due to the microfluidic approach, only sub-μl volumes of reagents and protein 
solutions needed to be used. Figure 3.14 shows the experimental protocol to in situ 
functionalize the superparamagnetic beads in the microchannel and to immunomagnetically 
capture/separate A549 cancer cells (a human lung carcinoma cell line) from a sample flow. 
Based on the specific interaction between wheat germ agglutinin and N-acetylglucosamine on 
the cell membrane, A549 cancer cells were effectively captured on the magnetic beads. Before, 
they were mixed with RBCs at a ratio of 1:10. The cancer cells were sorted with a capture 
efficiency of 62-74%. For the RBCs, no capture occurred under the same experimental 
conditions. HeLa-type and other types of cells were incubated with ferromagnetic beads that 
were fluorescently labeled prior to use. Due to the ferromagnetic, rather than 
superparamagnetic character, magnetic forces on such beads are larger. The cells showed a high 
uptake with 2-3 μm-size magnetic beads 92. In other work 93, incubation and external labeling 
of oral squamous carcinoma cells with 4.5 μm superparamagnetic beads was reported, followed 
by microfluidic separation of the labeled cells. Also apoptopic cells were selectively labeled 
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with magnetic microbeads and subsequently sorted in a microfluidic device. Jurkat cells have 
also been magnetically deposited on the bottom of a microfluidic channel that was held within 
an assembly of permanent and soft magnets 90. Jurkat cells were labeled with both magnetic 
nanoparticles and fluorescent labels using non-competitive sandwich immunoassay. A good 
magnetic capture efficiency (>99%) and the combination with optical (fluorescent) examination 
of the cell deposit are the advantageous features of this system. However, both FACS and 
immunomagnetic separation techniques rely upon laborious pre-processing and labeling of the 
cells using fluorescent probes and magnetic nanoparticles, respectively.  In addition to this the 
labels can be an hindrance when it comes to the next stage culture and or analysis of separated 
cells. 
 
Sorting cells, either for subsequent culture or to purify one cell type from a complex sample, is 
practiced using gravitational, chemical, optical, magnetic or mechanical methods. The most 
obvious type of on-chip physical cell separation is a filter structure that selects cells based on 
differences in size and disparity. Separation based on sedimentation is based on gravitation-
induced cell migration across individual fluid lamina with a lateral transport or migration 
velocity. The driving force of sedimentation is the difference in cell and fluid densities in the 
gravity field. For a mixture of similar cell types, the cell density, shape and cell size play a 
critical role in sedimentation. The main advantages of field-flow sedimentation are the absence 
of a label, the ability to continuously operate the device for high throughput, and the simplicity 
of the design. However, for cells with similar properties, such as during separation of cancerous 
cells from healthy tissue, there may not be sufficient difference in sedimentation parameters to 
achieve efficient separation. Dielectrophoresis using A.C. electrical fields is another physical 
method that has attracted attention. It is most effective when there is a significant size and 
dielectric difference between cell types. Dielectrophoretic force-based on-chip separation and 
retention of breast cancer cells (MDA231) from a diluted blood sample was demonstrated in 
1995 by Becker et al.94. They used a gold microelectrode array patterned on the bottom of a 
glass microfluidic chamber to generate dielectrophoretic forces on the cells. First they applied 
dielectrophoretic forces to separate different cell types and, following this, they flew a buffer 
solution inside the microfluidic chamber at a determined velocity thus applying hydrodynamic  
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Figure 3.15. The sequence of dielectrophoretic separation of human metastatic breast cancer 
cells (white in color) from a diluted blood sample. (A) After the activation of the electrodes 
cancer cells are seen separating from the blood cells.  (B) Selective washing step in which a 
buffer solution is flown from left to right. (C) The blood cells are washed away leaving only the 
cancer cells on the electrode tips. (D) In this image captured close to the outlet of the device, a 
stream of blood cells is seen being washed away in focused bands. (From reference 94) 
 
forces on the pre-separated cells. By adjusting the A.C. electrical fields and frequency, they 
were able to balance the dielectrophoretic forces and hydrodynamic forces specifically for 
breast cancer cells, while the other blood cells were washed-off by the flow (see Fig. 3.15). For 
dielectrophoretic force-based cell separation, external A.C. power sources are required and 
hence this technique is not a fore-runner for realizing a battery operated hand-held diagnostic 
device. Recently, Kwon et al.95 demonstrated the microfluidic separation of breast cancer cells 
(MCF-7) from normal breast epithelial cells (MCF-10A) based on the adhesion difference 
between these two cells. They incubated the cell mixture inside a polymer microfluidic channel 
and let the cell to adhere and grow by culturing them for 2 hours. Following this, they applied a  
flow providing the optimal shear force which removed the majority of normal cells from the 
co-culture. With this method, they were able to achieve about 80% of cancer cell capture 
efficiency. The potential drawback in this method is that, prior to separation, the cell mixture 
has to be cultured for several hours inside the microfluidic channel. 
 Chapter 3: State-of-the-art 
  
50 
 
Another widely used approach for microfluidic cancer cells separation, which is known as cell 
affinity chromatography96-98, relies on the immunoaffinity between the biomarkers (Ags) that 
are expressed on the cell surface and their respective Abs that are coated on the microfluidic 
channel surface or other cell capture structures. The specificity of Abs to match a desired Ag on 
the cell surface, the availability of established protocols to easily graft the channel walls with 
Abs and the feasibility to perform cell separation without using any external parts (like e.g. 
optical elements for FACS and magnets for immunomagnetic separation) has made this 
technique simple but yet more appealing than other cell separation techniques that were 
discussed before. Hence, in our work, we also use the same approach for separating the breast 
cancer cells (MCF-7) using self-assembled bead patterns (see chapter 6). 
 
 
Figure 3.16. Microfluidic chip based separation of lung cancer cells from whole blood sample 
using Ab-functionalized silicon microposts. (a) The experimental set-up used for the cancer cell 
separation. (b) Microfluidic chip with microposts. (c) Microfluidic chip assembly and the flow 
of blood through the cell capture chamber. (d) Scanning Electron Microscope image of a NCI-
H1650 lung cancer cell (pseudo colored red) captured by the micropost structure. The inset is 
the magnified image of a captured cancer cell. (From reference 86) 
 
In 2006, Du et al. 99 demonstrated the specific capture of cervical cancer cells (HCCC), in a 
PDMS microfluidic channel, from a mixed phase of cancer and normal cells (human glandular 
epithelial cells) present in a 1:1 ratio. They coated the channel surface with antibodies for 
α6−integrin where the latter is expressed on the cervical cancer cell surface.  
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Figure 3.17. Aptamer-based microfluidic device for sorting and detection of multiple cancer 
cells. (A) Schematic illustration of the microfluidic device used for separating three different 
types of cancer cells. In a single serpentine microchannel, three different aptamers are coated 
in regions 1, 2 and 3, respectively, using the appropriate well-pair as inlet and outlet for 
coating each region. (B) Schematic illustration of the specific interaction and capture of cancer 
cells by the immobilized aptamer molecules. (C-E) Representative image sets taken at one 
location pertaining to each aptamer coated region. Images in the first and second columns of 
each lane are fluorescent micrographs and the image in the third column is the overlay of the 
first two fluorescent images and a bright field image. (C) Red-stained CEM cells are 
specifically captured in the region 1 by sgc8 aptamer molecules, (D) green-stained Ramos cells 
are captured in the region 2 by TDO5 aptamer molecules and (E) unstained Toledo cells are 
captured specifically in the region 3 by sgd5 aptamer molecules. (From reference100) 
 
They reported a capture efficiency close to 50 % with 95 % purity. In 2007, Nagrath et al. 86 
demonstrated the selective capture of rare circulating lung cancer cells (NCI-H1650) from 
whole blood samples collected from early stage prostrate-cancer patients. They used anti-
epithelial-cell-adhesion-molecules (EpCAM), that were covalently grafted on several 
micropost-like structures that were etched on a silicon microchannel surface, for specific 
capture of the tumor cells from the whole blood sample (See Fig. 3.16).  Their device was able 
to capture as low as 5 circulating cancer cells per mL present in the clinical blood sample with 
close to 50 % purity. Also, Xu et al.100 reported the sorting of multiple cancer cells in a 
microfluidic channel using DNA-aptamers that are coated on the channel surface. Aptamers are 
peptide molecules that can bind selectively to a variety of molecular and cellular targets. In this 
study they showed the separation of CCRF-CEM cells (T-cell, human acute lymphoblastic 
leukemia), Ramos cells (B-cell human Burkitt’s lymphoma) and Toledo cells (non-Hodgkin’s 
B-cell lymphoma) from a non-clinical sample mixture, in a single microfluidic channel, using 
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three distinct cell capture regions formed by the coating of their respective cell-capture 
aptamers (See Fig. 3.17). They reported a 135-fold enrichment of these rare cancer cells with 
96 % purity. 
3.3.2 Cancer bio-markers detection in a microfluidic chip 
Identification of the spectrum of bio-molecular (DNA, RNA, proteins) markers or bio-markers 
expressed on the tumor cell surface or in any diagnostic body fluid is of growing importance, as 
it can not only pave the way for non-invasive early diagnosis and prognostic evaluation of 
cancer, but also it forms the basis for choosing the right mode of therapy (also known as 
targeted therapy). For example, in breast cancer patients, ascertaining the estrogen receptor 
(ER) and the epidermal growth factors receptor (EGFR) levels are quite important before 
deciding on the mode of therapy. If ER is over-expressed, then hormonal therapy can be 
prescribed to suppress the estrogen production whereas if EGFR is over-expressed then drugs 
that will block the same can be prescribed. This way, even for the same kind of cancer, 
personalized therapy which targets the bio-marker(s) of interest is possible101.  However, the 
cost and complexity involved in the biomarker screening has so far restricted it to the research 
laboratory settings and in order to transform the same to the clinical settings, point-of-care 
devices based on microfluidics are required. 
 
In 2005, in a pioneering work, Zheng et al.102 demonstrated the electrical detection of multiple 
prostate cancer bio-markers using silicon nanowire based field-effect transistors as sensor 
arrays102 (See Fig. 3.18). First they grafted the surface of the nanowire arrays with specific 
capture Abs for cancer biomarkers and then exposed them to the samples using a PDMS 
microfluidic channel sealed to the sensor chip. Detection and quantification of the bio-markers 
was done by measuring the change in the conductance of the nanowire sensors. Their device 
was able to detect the presence of prostate specific antigen (f-PSA), PSA-
α1−antichymotrypsin, carcinoembryonic antigen and mucin-1 of concentrations down to 0.9 
pg/mL from undiluted serum samples. In 2008, Ko et al.103 demonstrated the simultaneous 
electrical detection of three prostate cancer biomarkers from a non-clinical sample using a 
bead-based microfluidic assay. Their microfluidic chamber consisted of a pillar-type microfilter 
for retaining the capture Ab-coated polystyrene beads and an integrated interdigitated electrode 
for detecting the bio-marker level based on conductance change. 
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Figure 3.18. Nanowire sensor array-based multiplexed electrical detection of cancer 
biomarkers. (a) Optical image of a nanowire sensor array (top) and a schematic of the 
electrical connections which are represented as golden lines for addressing nanowires which 
are represented as black lines, respectively (bottom). (b) Schematic illustration of two 
nanowires (part of an array) coated with capture Abs for specific capture of cancer biomarkers 
(in picture rose and grey). (c) Calibration curve for prostate specific antigen (PSA) 
concentration based on the measurements done using a nanowire device. The inset of (c) shows 
the sensor output i.e. the conductance change recorded after alternate delivery of PSA and 
pure buffer solutions; each peak, from left to right, in the recording corresponds to a PSA 
concentration in the following order: 0.9 ng/mL, 9 pg/mL, 0.9 pg/mL and 90 fg/mL. (From 
reference102) 
 
Immuno-complexes were formed by first exposing the beads to a sample flow, resulting in the 
capture of specific biomarkers and thereafter by exposing to a flow of secondary Abs labeled 
with 10 nm gold particles. As an output signal amplification strategy, the gold nanoparticles 
were enlarged by 20-30 times, using silver enhancer solution, resulting in the direct connection 
between the gold nanoparticles present on the adjacent microbeads and on the electrodes. This 
amplified the biomarker detection signal by increasing the conductance of the detector. Using 
this approach they were able to detect bio-marker concentrations down to 1 ng/mL. Recently, 
Liu et al.104 demonstrated a microfluidic electrochemical ELISA for the detection and 
quantification of cancer biomarkers using differential pulse voltametry. As a proof-of-concept 
they showed the detection of α-fetoprotein hepatocellular carcinoma biomarker down to a 
concentration of 1 pg/mL. A cell-based lab-on-a-chip platform for the capture of oral tumor-
derived cell lines and subsequent EGFR biomarker detection using a non-clinical sample was 
reported by Weigum et al.88. In this work, a 0.4 μm track-etched membrane was integrated with 
a PMMA microfluidic channel and used as a filter element to retain the cells from a cell  
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mixture solution (See Fig. 3.19). Following this they performed the EGFR protein expression 
analysis using the assay-specific fluorescent labeling (cell immunofluorescence). 
 
Figure 3.19. Membrane based lab-on-a-chip sensor platform for cancer cell analysis. (a) 
Exploded view of the lab-on-a-chip device assembly with an integrated  track-etched membrane 
used for cancer cell capture and analysis. (b) Cross-sectional view of a fully assembled 
membrane-based lab-on-a-chip device. (c) SEM image of the track-etched membrane before 
(left) and after (right) cancer cell capture. (From reference88) 
 
3.3.3 Conclusion 
The work that has been presented here has demonstrated that the microfluidic chips can be 
useful for cancer diagnostics, for choosing the mode of therapy and as well provide an efficient 
tool for real-time monitoring of the response to a chosen therapy, thus holding a future promise 
for effectively assist oncologists and pathologists directly in clinical settings. Though cancer 
cell separation is a basic and very important step in microfluidic chip-based cancer diagnosis 
and prognosis, it will prove useful to culture and perform further studies and analysis on these 
captured cells e.g. drug screening, bio-marker detection, DNA-RNA analysis etc.. To address 
this problem, we will demonstrate a simple and integrated approach to separate the target 
cancer cells from a cell mixture using self-assembled protein coated beads followed by their 
subsequent culture and analysis (see Chapter 6). Also, when it comes to cancer staging and 
prognosis, present FDA regulations make it mandatory to investigate the biopsied tissue. This 
clearly shows that still more room is left for applying microfluidic chip technology, in assisting 
anatomy pathologists, in analyzing the biopsied tissues in a cost-efficient, rapid and automated 
manner with a high detection sensitivity. In our work, we therefore have demonstrated a highly- 
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sensitive immunohistochemical analysis on paraffin-embedded breast-cancer tissues in a 
microfluidic chip format (See chapter 7). 
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4.1Introduction 
Numerous bio-assays are based on the patterning of proteins using micro- and nano-
technologies. Different techniques used for protein micropatterning have been already 
discussed under Chapter 3. Protein microarray technology permits the high-throughput 
screening and analysis of several proteins in a single experiment1, 2. Integrated microfluidic 
analytical systems3 offer the advantage of strong analysis time reduction due to the small 
molecular diffusion distance, while consuming minute quantities of samples and reagents. 
However, these systems demand preparation and chemical activation of the binding surface, 
which impose additional treatments of the microchannel or reaction support. While printing or 
spotting of protein micro-patterns is a common technique, the use of protein-coated nano- or 
micro-particles offers additional advantages, like an enhanced specific binding surface, a wide 
range of available bead surface chemistries and an easy recovery from the bio-analysis chip. 
Moreover, when microbeads incorporate a magnetic core, they can be easily manipulated using 
magnetic fields, irrespective of fluid flows4-6. Functionalized beads are widely commercially 
available and beads that are immobilized or micropatterned on surfaces are already used as 
platform for performing immunoassays7, target DNA detection8, as a scaffold for patterned cell 
culture studies9, and as nucleation sites for growing and attaching permanent magnetic chains10. 
A number of bead patterning techniques on substrates has been proposed in the literature. The 
substrate may contain microcavities in which beads are physically trapped , or magnetic beads 
are locally immobilized using magnetic fields11. In the former case the trapped beads are not 
sticking to the surface and can be easily washed away, whereas the later method requires 
permanent magnets or electromagnets, making the system either bulky or complex. Also, one 
can use appropriate chemistries for attaching beads at selected areas of the substrate. Biotin-
streptavidin interaction chemistry was used as the base for patterning streptavidin-coated beads 
on a template of biotinylated proteins12, created by microcontact printing. However, the 
mechanism of transferring proteins from a stamp to the surface is non-trivial and very often the 
micro-contact-printed protein pattern has imperfections (see Chapter 3).  Alternatively, 
electrostatic interactions have been used as a tool for attaching charged particles to oppositely-
charged surface patterns13. The ease of surface charge patterning using conventional 
microfabrication techniques or by microcontact printing, makes this technique very attractive 
for patterning charged colloidal particles13-16. Patterned polyelectrolyte multilayers14 and silane 
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layers17 have already been successfully used as a template for patterning a variety of charged 
polymer beads. Beads that were not functionalized with proteins were used in these studies. 
 
In this chapter, we show how protein-functionalized magnetic beads can be micropatterned on a 
glass surface using electrostatic interactions. Moreover, we use this technique for 
micropatterning protein-coated beads in situ in microfluidic channels with high reproducibility 
and in a matter of minutes. Streptavidin-coated magnetic beads are immobilized in the form of 
stripes and dots, whereby the exact arrangement and the number of immobilized beads can be 
controlled by the size of the micropatterned template layer. Our method has large potential, as 
the proposed electrostatic interaction technique could allow the micropatterning of a wide 
variety of protein-coated beads on a single substrate, and may play a role in the development of 
future lab-on-a-chip bead-based bio-assays.  
 
This chapter is an adapted version of the following journal article: 
• V. Sivagnanam, A. Sayah, C. Vandevyver and M.A.M. Gijs. Micropatterning of 
protein-functionalized magnetic beads on glass using electrostatic self-assembly. 
Sensors and Actuators B, 2008, Vol. 132, pg. 361-367. 
 
4.2 Experimental 
4.2.1 Materials 
(3-aminopropyl)triethoxysilane (APTES) solution, phosphate buffered saline (PBS) solution of 
pH 7.4 and the non-ionic surfactant Tween-20 (which is Polyethyleneglycol (20) sorbitan 
monolaurate) were purchased from Sigma-Aldrich Chemie GmbH (Buchs, Switzerland). The 
PBS-Tween (PBST) solution (~ pH 7.4) was prepared by mixing 0.5 % v/v of Tween- 20 with 
PBS. The streptavidin-coupled bead solution, Dynabeads® M-270 and Dynabeads® MyOneTM 
of bead diameter 2.8 μm and 1 μm, respectively, were purchased from Invitrogen AG (Basel, 
Switzerland). The stock concentration of Dynabeads® M-270 bead solution is 10 mg (~ 6.7 x 
108 beads) per ml and that of Dynabeads® MyOneTM is 30 mg (~ 2.0 x 109 beads) per ml, 
respectively. The negative photoresist SU8-50 and the positive photoresist AZ1512 were 
purchased from Microchem Corp. (MA, USA) and Shipley Europe Ltd. (Cheshire, UK), 
respectively. Poly-(dimethylsiloxane) (PDMS) pre-polymer and curing agent (Sylgard 184) was 
purchased from Dow Corning (MI, USA). Float glass wafers (Ø 4 in.) and deionized (D.I.)  
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Figure 4.1. Schematic illustration of the micropatterning process of streptavidin-coated beads 
on a APTES template using electrostatic self-assembly. (a) Positive photoresist micropattern on 
an glass substrate (b) Spin-coating of the APTES layer. (c) Lift-off of the photoresist using 
ultrasonication. (d) A droplet of streptavidin-coated beads in PBS or PBST is incubated on the 
substrate. (e) Pattern of self-assembled beads after rinsing. 
water of resistivity 18.2 MΩ-cm were obtained from EPFL’s Center of Micro- and 
Nanotechnology. Ethyl vinyl acetate tubes (Micro-line model) of 0.51 mm inner diameter were 
purchased from Fischer Scientific (Wohlen, Switzerland). Syringe pump (neMESYS) was 
purchased from Cetoni GmbH (Korbussen, Germany). 
 
4.2.2 Characterization 
Atomic force microscopy (AFM) was performed at room temperature in tapping mode (spring 
constant 48 N/m) using a Nano instruments Nanosurf DT-40 to determine the thickness of the 
patterned APTES layer. Optical microscopy and scanning electron microscopy (SEM) was used 
to study the bead adsorption and bead patterning on glass. Optical micrographs were captured 
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using a digital camera mounted on a Zeiss Axioskop 2 FS Plus. Prior to SEM imaging using a 
Philips XL30 FEG, the samples were coated with a 30 nm gold layer by sputtering. A stylus-
based surface profiler (Tencor Alpha step-500) was used to measure the thickness and width of 
the SU-8 micropatterns that form the mold structure used for replicating microfluidic channels 
in PDMS. 
 
4.2.3 Methods 
Bead patterning on a glass substrate 
The schematic in Figure 4.1 illustrates the method of micro-patterning protein-coated beads on 
a glass substrate using APTES patterns as the template for bead adsorption. The positive 
photoresist AZ1512 was spin-coated on a float glass substrate and patterned using standard 
photolithograpy (Fig. 4.1a). Then the exposed glass area was subjected to air plasma (Harrick 
plasma cleaner) for 40-60s, resulting in the creation of surface silanol groups. Following this, 1 
% v/v APTES solution in D.I water was spin-coated at 5000 rpm for 20s, where after the wafer 
was baked at 100 °C for 2 minutes (Fig. 4.1b). This results in the covalent binding of the 
APTES molecules to the glass surface through a condensation reaction. Then the structured 
photo-resist was ultrasonically lifted-off in acetone resulting in APTES micropatterns on the 
glass substrate (Figure 4.1c). The realized APTES patterns consisted of dot and stripe-arrays 
with dot diameters and stripe widths ranging from 2 to 10 μm. The spacing between any two 
consecutive dots or stripes is maintained as 20 μm. Fig. 4.2a and Fig. 4.2b shows the optical 
micrograph and the tapping mode AFM image of an APTES pattern, respectively, and in these 
pictures the ridges/edges of the APTES patterns can be clearly seen. The average ridge 
thickness was in the range of 150-250 nm, while in between, the APTES film thickness was 
only 30-70 nm. The origin of the ridge effect is the capillary force acting between the APTES 
solution and the vertical side walls of the photoresist patterns. This capillary effect will cause 
the formation of an APTES meniscus and thus, during curing, results in an accumulation of 
APTES molecules at the photoresist sidewalls (Fig. 4.1 b-c). For patterning of beads, a droplet 
of magnetic bead solution, 2 times diluted (Ø 2.8 μm) or 6 times diluted (Ø 1 μm) from the 
stock solution, is spread over the APTES pattern on 2 cm x 2 cm substrate area  and incubated 
for 7-10 minutes (Fig. 4.1d). This time is sufficient for complete bead sedimentation. Finally, 
rinsing of substrate is done in PBS for a minute leaving the magnetic bead pattern of Fig. 4.1e. 
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For the case of magnetic field assisted bead patterning, immediately after spreading the bead 
droplet over the APTES patterns, a NdFeB permanent magnet was placed beneath the glass 
substrate for about 15-20 s. Thereafter, the magnet is removed and rinsing is done as mentioned 
before. 
 
 
 
Figure 4.2. (a) Optical micrograph showing an array of APTES stripes with the ridges formed 
at the stripe boundaries originating from the lift-off micropatterning process. (b) An AFM 
image showing a single APTES stripe pattern.  
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In-situ bead patterning in a microfluidic channel 
Microfluidic chip fabrication and set-up 
For in-situ micropatterning of protein-coated beads inside a microchannel, we fabricated a 
microfluidic chip by reversibly bonding a PDMS piece containing a microfluidic channel to a 
glass-substrate having the APTES template patterns, as schematically shown in Fig. 4.3. During 
bonding, alignment between the microfluidic channel and the APTES pattern is not required as 
the latter is present all over the glass surface. The microfluidic channel on PDMS was realized 
by the replica molding technique18. The master structure for replica molding was realized by 
generating 50 μm and 100 μm wide microfluidic channel patterns in a 50 μm and 65 μm thick 
SU-8 photoresist layer. A 10:1 mixture of PDMS pre-polymer and the curing agent was cast 
over the master and then cured at 70 °C for 4 hours. Then the cured PDMS replica was peeled-
off from the mold and access holes of 1 mm diameter for the inlet and outlet tube connections 
were made by piercing the replica using a blunt needle. In order to ensure a leak-proof sealing, 
the microfluidic chip was clamped in between two poly(methyl methacrylate) (PMMA) plates, 
with the top plate having the holes for inlet and outlet tubes. In-situ bead patterning was 
performed in two modes, viz. static and dynamic, and the respective patterning procedures are 
described below. 
 
 
 
 
Figure 4.3. Schematic of a microfluidic channel used for electrostatic self-assembly of 
streptavidin-coated beads. The channel is formed by reversibly sealing a PDMS replica with a 
glass substrate having APTES patterns. 
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Static-mode patterning 
Fig 4.4a schematically illustrates the static-mode patterning procedure. The bead solution       
(Ø 1 μm, 5x dilution), was introduced inside the microfluidic channel and was incubated under 
static or no-flow conditions for 7-10 minutes (Fig 4.4a (i)). Washing was done by flowing PBS 
(50 nL/s) for 2 minutes resulting in the bead patterns (Fig 4.4a (ii)). 
 
Dynamic-mode patterning 
In contrast to static-mode patterning, dynamic-mode patterning was done under a continuous-
flow of the bead solution (Ø 1 μm, 6x dilution), at 5 nL/s, inside the microchannel as shown in 
Fig 4.4b (i). First the bead solution was driven in the forward direction for 1-2 minutes and then 
in the opposite direction for a minute. Final washing was done in PBS, at 50 nL/s, for 2 
minutes. In this patterning mode, beads selectively adsorb on the projected ridges of the 
APTES templates (Fig 4.4b (ii)). 
 
 
 
Figure 4.4. Schematic illustration of the in-situ patterning of beads in a microfluidic channel  
in static-mode (a) and dynamic-mode (b). 
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4.3 Results 
4.3.1 Electrostatic adsorption mechanism 
At pH  8, the NH2 groups of the APTES layer are protonated to NH3+,17, 19  resulting in a 
positive surface charge to which negatively-charged particles adsorb by long-range electrostatic 
forces. As the iso-electric point (pI) of streptavidin is around 5.0,20 the streptavidin coated 
beads have a negative-surface charge at pH values above 5.0. The 2.8 μm and 1.05 μm sized 
streptavidin-coated beads used in this work have a surface potential of -50 mV and -35 mV, 
respectively, at pH 7.21 Figure 4.5a shows the streptavidin-coated beads adsorbed on the 
APTES layer at the physiological pH (7.4). However, when the pH of the bead solution is less 
 
 
Figure 4.5. Optical micrograph showing streptavidin-coated beads (Ø 2.8 μm) in PBS 
adsorbed on the APTES layer at: (a) pH 7.4 and (b) pH 2.5 
 
than the protein pI, the beads acquire a positive surface-charge, resulting in the inhibition of 
bead adsorption on the APTES due to repulsive electrostatic interactions. In the optical 
micrograph of Fig. 4.5b, it can be seen that only a very few beads are adsorbed on the APTES 
layer when the beads are incubated at a pH of 2.5. We also tested if the beads adsorbed at pH 
7.4 could be desorbed by rinsing in a PBS solution of pH 2.5. We found that the binding 
kinetics of the adsorbed beads cannot be reversed by changing the pH of the solution. 
Apparently, the adsorbed beads bind very strongly to the APTES-coated substrates; however, 
they can be removed using ultrasonication during a few seconds. Thereafter, thanks to their 
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magnetic nature, they can be easily collected using external magnetic fields for further 
processing or off-chip analysis. 
4.3.2 Bead patterning on glass substrates 
The APTES layer patterned on the glass substrate is used as the template for bead patterning 
through electrostatic self-assembly at pH 7.4. At this pH, the glass is negatively charged due to 
the deprotonation of silanol groups22, which should result in a bead-repulsive and adsorption-
resistant surface. However, when we incubate the beads at pH =7.4 on the APTES template, we 
notice that the beads adsorb non-specifically on the glass surface and not only on the APTES 
micropatterns, as shown in the Fig. 4.6a. 
 
 
Figure 4.6. Beads patterned on an APTES template at pH 7.4 using (a) PBS solution and (b) 
PBST solution. 
 
The non-specific adsorption of beads on the glass surface can be attributed to the Hamaker 
constant of the bead-solution-surface system16, 23 and to the possible hydrogen bonding between 
proteins (coated on the bead surface) and the Si-OH or Si-O- groups on the glass surface.  In 
order to overcome this problem, we added a non-ionic surfactant, 0.5 % v/v of Tween-20, to the 
PBS medium in which the beads are dispersed. The optical micrograph in Fig. 4.6b shows the 
results of bead pattering using the PBST buffer. From Fig. 4.6b, it is obvious that the use of 
surfactant completely inhibits the non-specific adsorption of beads to the glass surface without 
affecting the electrostatic-force-driven selective adsorption of beads on the APTES pattern. 
This result can be attributed to the following reason: the hydrophobic portion of the Tween-20 
molecules bind to the hydrophobic patches of the streptavidin coated on the bead surface, 
whereas the hydrophilic poly-ethylene-glycol (PEG) moieties of Tween-20 are exposed to the 
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aqueous buffer. The PEG monolayer that is present on the bead surface, with its unique 
hydration nature24, 25, strongly binds water molecules and thus eliminates the bead adsorption 
on the glass. 
 
 
Figure 4.7. Optical micrographs showing streptavidin-coated beads (Ø 2.8 μm) patterned in 
the form of singlet and doublets on the dot-arrays of dot size 2 μm (a) and 3 μm (b), 
respectively. (c-d) SEM micrographs showing streptavidin-coated beads (Ø 2.8 μm) patterned 
in the form of stripe arrays of stripe width 3 μm (c) and 2 μm (d), respectively. 
 
We patterned the beads in the form of dot and stripe arrays, as shown in the optical and SEM 
micrographs of Fig. 4.7. The maximum number of beads that can be self-assembled per APTES 
dot depends on the dot size and the bead size. As can be seen in Fig. 4.7a, when a 2 μm sized 
APTES dot-pattern is used as template, we can realize single bead dot-arrays. When the 
APTES dot size is 3 μm, then two beads self-assembled per dot, as shown in Fig. 4.7b. The 
good uniformity of the bead patterning is representative for the complete glass substrate area. 
These results are in agreement with those reported by the group of Hammond, who showed that 
the number of charged spheres of size d, trapped per oppositely charged dot template of size D, 
depends on the ratio of D/d15. We also noticed that, as the bead dilution increases, the number 
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of pattern defects also increases, thus affecting the uniformity of the bead patterning. For the 
case of 2.8 μm beads patterned on APTES dots, using a bead solution diluted  2 times from 
stock solution, it is possible to achieve uniform bead patterning, as shown in Fig. 4.7a and 4.7b, 
with high reproducibility. Lower bead concentrations and reduced bead incubation times lowers 
the APTES pattern-bead interactions, and lead to non-uniformities in the bead patterns. Also 
for the APTES stripe pattterns, the stripe width determines the number of beads adsorbed along 
its width.  Fig. 4.7c and 4.7d show closely packed chains made of pairs of beads and single 
beads on APTES stripe patterns of a width of 3 μm and 2 μm, respectively. From the insets of 
Fig. 4.7c and 4.7d, it can be seen that there is a small gap between two adjacently adsorbed 
beads that is due to the inter-particle electrostatic repulsive forces originating from the 
streptavidin groups. This inter-particle gap is about 150 nm. 
 
External magnetic forces can be used to accelerate the electrostatic self-assembly of the beads 
as the latter are superparamagnetic in nature. Apart from the advantage of scaling down the 
time required for bead patterning, magnetic forces can also be used as the basis to concentrate 
the beads, on the desired areas of the chip, even from a relatively highly-diluted bead solution. 
To demonstrate these two advantages of the magnetic field assisted electrostatic self-assembly, 
we used a 15x diluted bead solution (Ø 2.8 μm) and an incubation time of ~15 s and 7 minutes 
for the incubation of bead solution with and without the magnetic field, respectively. Fig. 4.8 
displays two representative optical micrographs which compare the effect of self-assembly of 
streptavidin-coated beads, with or without the influence of magnetic field, on an array of 2.5 
μm APTES stripes. Defect-free bead patterns were obtained in a matter of seconds (~15 s) 
under the application of magnetic field (Fig. 4.8 b), whereas, when no magnetic field was used, 
the resulting bead patterns had a lot of defects, as shown in Fig. 4.8 b. These defects can be 
mainly attributed to the low bead concentration. Though defect-free patterns were possible 
without the application of a magnetic field, as demonstrated previously (see Fig. 4.6 b and 4.7 
c-d), in those experiments the time used for incubation was about 7 minutes and also a 
relatively highly-concentrated bead solution (only 2x diluted from the stock solution) was used. 
Clearly magnetic field-assisted electrostatic self-assembly can be particularly useful when 
working with nanometer sized particles, as the latter can take several tens of minutes to diffuse 
to the surface. Also this technique gives the possibility to work with a low concentration of 
bead solution, and hence is cost-effective as the bead solution wastage is reduced. 
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Figure 4.8. Self-assembly of streptavidin beads with the application of magnetic field (a) and 
without magnetic field (b). Bead incubation time was only 20 s for (a) and 7 minutes for (b). 
 
4.3.3 In-situ bead patterning in a microfluidic channel 
As discussed in Chapter 3 (section 3.15), in-situ patterning of proteins inside fully-packaged 
microfluidic chips26 is an important step for the realization of microfluidic biochips and other 
point-of-care clinical diagnostic devices7. Therefore, we extend our research to the patterning 
of streptavidin-coated beads in-situ in microfluidic chips. 
 
Static-mode patterning 
 
Figure 4.9a shows a microfluidic channel of 50 μm x 50 μm cross-section filled with a bead 
solution containing 1 μm streptavidin-coated beads; this picture was taken 10 minutes after 
filling the microchannel with the bead solution. The glass surface of the microfluidic chip 
consisted of an APTES dot (Ø = 4 μm) array with a pitch of 20 μm. It can be clearly seen that 
the beads are preferentially adsorbed on the APTES dot array, as indicated by the circle drawn 
in the micrograph. The micrograph of Fig. 4.9b, shows the resultant bead patterns obtained 
after flushing the free beads out of the microfluidic channel using PBS at a rate of 500 μl/min. 
Fig. 4.9c is a representative micrograph of beads patterned in the form of stripes in-situ inside 
the microchannel. 
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Figure 4.9. Optical micrographs showing streptavidin-coated bead patterning in situ in a 
microfluidic channel. (a) Beads (Ø 1.05 μm) in Brownian motion and adsorbed on the APTES 
dots are visible. (b) The unadsorbed beads are washed away by flowing a PBS solution through 
the channel. (c) Beads patterned in the form of stripes. 
 
Dynamic-mode patterning 
 
The image sequence in Fig. 4.10 shows that, as the bead solution is flown continuously through 
the microchannel, the beads start to stick on the two edges of each of the APTES stripes. The 
APTES stripe had a width of 5 μm and the pitch between the adjacent stripes was of 20 μm. 
Due to the protruding ridges of the APTES patterns, the beads under laminar flow have a high 
probability to only interact and stick to the edges of the APTES stripes rather than their inner-
space. Thanks to the dynamic-mode patterning and ridge effect, bead patterns in the form of 
single-bead chains (Ø 1 μm) were possible, even on patterns as wide as 5 μm, without 
demanding a very high APTES stripe pattern resolution (1 μm or less). The self-assembled 
beads bind strongly to the APTES and they are able to withstand flow rates as high as 10 mm/s. 
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Figure 4.10. Snap-shot images from a video grabbed during the process of bead (Ø 1.05 μm) 
patterning in dynamic-mode in a microfluidic channel of cross-section 100 μm (width) x 65 μm 
(height). The direction of flow is indicated by the arrow mark. No bead patterns are visible five 
seconds after starting the flow of beads (a). However, after a minute of bead-flow the patterns 
can be seen emerging with beads sticking on the edges. As the flow direction is from left to 
right in (a-b), more beads stick to the upstream/left ridge of each APTES pattern compared to 
the downstream/right ridge. To help the beads to quickly stick on the right ridges, the bead flow 
direction changed as shown in (c). After 2 minutes the patterning is almost complete and 
subsequently final washing was performed resulting in bead patterns in the APTES pattern 
ridges (d) (Scale bar: 20 μm) 
 
4.4 Conclusion 
We have demonstrated the patterning of streptavidin-coated beads both on substrates and in situ 
in microchannels using electrostatic self-assembly. The bead patterning method presented here 
is simple and cost-effective, as only one photolithography step is involved in the fabrication of 
the APTES template pattern. We have demonstrated the patterning of beads on a glass surface, 
but the same approach can also be used for bead patterning on other oxidizable substrates to 
which APTES can be covalently coupled, like silicon, metal etc.. Not only streptavidin-coated 
beads, but also beads coated with other proteins should be patternable through electrostatic 
forces-mediated self-assembly. Our streptavidin beads patterned in-situ in microchannels have 
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high potential to be used in microfluidic platforms for performing lab-on-a-chip, bead-based, 
immunoassays (see next chapter). 
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5.1 Introduction 
 
In this chapter we present two different microfluidic bio-applications based on the streptavidin-
coated bead micropatterns generated via electrostatic self-assembly as explained in the previous 
chapter. This chapter is an adapted version of the following journal articles: 
• V. Sivagnanam, B. Song, C. Vandevyver and M.A.M. Gijs. On-chip immunoassay 
using electrostatic assembly of streptavidin-coated bead micropatterns. Analytical 
Chemistry, 2009, Vol. 81, pg. 6509-6515. 
 
• V. Sivagnanam, B. Song, C. Vandevyver and M.A.M. Gijs. Selective breast cancer cells 
capture, culture and immunocytochemical analysis using self-assembled magnetic bead 
patterns in a microfluidic chip. Revised version submitted to Langmuir, Dec. 2009. 
 
As the first application, we demonstrate a full on-chip immunoassay using magnetic beads as 
assay substrate. As a model analyte for the immunoassay, we used mouse Ag (m-Ag) diluted in 
a PBS solution with 1% (w/v) BSA. The immunoassay was performed in both stop-flow and 
continuous-flow modes. In stop-flow mode, the microchannel volume (130 nL) was filled and 
incubated with the sample in a step-wise fashion, whereas, in the continuous-flow mode the 
sample was flown inside the channel at a constant flow rate. The quantification of target Ag 
was done using a conventional fluorescent microscope set-up. For the stop-flow mode assay, 
we studied various target Ag concentrations (0-150 ng/mL) and incubation volumes (130-1300 
nL). In the continuous-flow mode, we varied the sample concentration (0-1 ng/mL) while 
flowing 1300 nL of the sample through the microchannel. We also demonstrate the possibility 
of simultaneous detection of multiple Ags from a sample solution that contains a mixture of m-
Ag and rabbit Ag (r-Ag), when using bead micropatterns in a dual microfluidic system. 
 
As the second application, we present a combined approach for target cell separation, culture 
and subsequent analysis in a microfluidic chip using protein-coated bead micropatterns as the 
cell capture and culture substrate. For demonstrating this application we used MCF-7 epithelial 
breast cancer cells mixed with Jurkat cells as the model target and negative-control cells, 
respectively. The beads were coated with two proteins: 5D10 monoclonal Ab (mAb) and 
fibronectin (FN), where the former is used for target cell capture based on the immunoreaction 
while the latter promotes adhesion and growth of captured cells. Following the cell culture an 
immunocytoluminescent analysis was perforrmed on the cultured cells for the detection of 
5D10 biomarker expressed on the MCF-7 cell surface. 
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5.2 Application I: Immunoassay 
5.2.1 Experimental 
5.2.1.1 Chemicals and Materials 
APTES solution (product no. 440140), PBS 10x concentrate solution (product n° 5493) and the 
non-ionic surfactant Tween-20 (product no. 1379) were purchased from Sigma-Aldrich Chemie 
GmbH (Buchs, Switzerland). The streptavidin-coupled bead solution, Dynabeads® MyOneTM 
of bead diameter 1.05 μm was purchased from Invitrogen AG (Basel, Switzerland). The stock 
concentration of Dynabeads® MyOneTM is 30 mg (~ 2.0 x 109 beads) per ml. 1x PBS (0.15 M, 
pH =7.4) was prepared by diluting 10x PBS concentrate solution; PBS-BSA solution was 
prepared by diluting 1% (w/v) of BSA (product no. A7030, Sigma-Aldrich) in 1x PBS. The 
PBS-Tween (PBST) solution (~ pH 7.4) was prepared by mixing 0.5 % v/v of Tween-20 with 
1x PBS. Biotinylated polyclonal goat anti-mouse IgG (mouse-capture Ab, product no. B-2763), 
normal mouse IgG target Ag (m-Ag, product n° 10400C), Alexa Fluor 488-labeled polyclonal 
goat anti-mouse IgG (green mouse-detection Ab, product no. A-11029), biotinylated polyclonal 
goat anti-rabbit IgG (rabbit-capture Ab, product no. B-2770), normal rabbit IgG target Ag (r-
Ag, product no. 10500C) and Alexa Fluor 647-labeled polyclonal donkey anti-rabbit IgG (red 
rabbit-detection Ab, product no. A-31573), were purchased from Invitrogen AG (Basel, 
Switzerland). Cy3-labeled polyclonal goat anti-mouse IgG (orange mouse-detection Ab, 
product no. 610-104-121) was purchased from BioConcept (Allschwil, Switzerland). Atto488-
labeled-biotin (product no. 30574) was purchased from Sigma-Aldrich. All the Abs and Ags 
were diluted in PBS-BSA solution. After preparation of the reagent solutions to the desired 
concentration, they were filtered by a 0.45 µm pore size membrane. 
5.2.1.2 Microfluidic chip fabrication and set-up 
The microfluidic chips were fabricated by reversibly bonding a PDMS replica containing the 
microfluidic channel structure to the glass-substrate having the APTES patterns. Fig. 5.1 shows 
the single and dual microchannel structures, used for the single-Ag assay and simultaneous 
two-Ag detection, respectively. Both types of channel have a width of 100 μm, a height of 
either 65 μm or 20 μm and a total length of 20 mm. Then the PDMS replica was peeled-off  
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Figure 5.1. Schematic diagram of the single (i) and dual (ii) microfluidic channel structures 
with indication of the zones where the beads are functionalized with mouse capture Ab and 
rabbit capture Ab. 
 
from the mold and access holes of 0.5 mm diameter for the inlet and outlet tube connections 
were made by piercing the replica using a blunt needle. In order to ensure a leak-proof sealing, 
the microfluidic chip was clamped in between two PMMA plates, with the top plate having the 
holes for inlet and outlet tube access. The microfluidic chip was mounted on a microscope set-
up and a neMESYS syringe pump generates the positive pressure used for injecting the bead 
and reagent solutions through the microchannel. 
 
For the stop-flow mode assay, we used a flow rate of 5 nL/s for application of the bead 
solution, 25 nL/s for the analyte and reagent solutions and 50 nL/s for the washing solution; for 
the continuous flow mode assay, we used 2 nL/s for the bead solution, 5 nL/s for all the reagent 
and washing solutions, except for the m-Ag (analyte) solution which was flown at 0.25 nL/s. 
The two-Ag detection assay was performed in the stop-flow mode. The pump user interface 
software is used to control the flow rate. 
5.2.1.3 Immunoassay protocol 
Sandwich (two-step) immunoassay for m-Ag detection in static-mode and 
continuous-flow mode 
After the bead micropatterning process, the microchannel walls were blocked using PBS-BSA 
1% solution for ~2 min. This step is essential to avoid the unspecific adsorption of Abs/Ags on 
the microchannel walls. Following this, we grafted the biotin-labeled capture Abs on the bead 
surface by flowing 10 μg/mL of capture Ab solution inside the microchannel and let it incubate 
for 2 min. After washing with PBS solution, the target Ag solution was introduced. For the 
stop-flow mode immunoassay, the microchannel volume (130 nL) was filled and incubated 
with the Ag solution in a step-wise/incremental fashion and the total number of filling steps 
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determined the Ag solution volume used in the assay. For example, incubation of 1300 nL was 
based on 10 consecutive filling/incubation steps, each one taking 2 min. We performed assays 
using three different target m-Ag solution volumes, namely 130 nL, 520 nL and 1300 nL. The 
m-Ag concentrations used in the stop-flow mode immunoassay experiments were in the range 
of 0-150 ng/mL. 
 
For the sandwich immunoassay experiments in continuous-flow mode, in total 1300 nL of m-
Ag solution, in the concentration range of 0-1 ng/mL, was flown inside the channel at a 
constant flow rate of 0.25 nL/s. Hereafter, we washed the channel using PBS solution and then 
the channel was filled and incubated with mouse-detection Ab solution (10 μg/mL) for 2 min. 
Final washing was performed by flowing PBST 0.05% solution for 2 min. 
Direct (single-step) immunoassay in continuous-flow mode 
For direct immunoassay trials in continuous-flow mode, immediately after patterning the beads 
and blocking the channel with PBS-BSA, we flowed 500 nL of 100 pg/mL of atto488-labeled-
biotin solution. Hereafter, final washing was performed by flowing PBST 0.05% solution for 2 
min. 
Simultaneous detection of Two Ags 
For the simultaneous detection of two Ags, immediately after patterning the beads and blocking 
the channel with PBS-BSA, we coated mouse-capture Abs and rabbit-capture Abs on the beads 
patterned in the upper and lower part of the dual microchannel structure, respectively (see Fig. 
5.1 (ii)). This was done by filling each microchannel with its respective capture Ab solution 
through suction from the inlet, followed by washing the microchannel using PBS solution. 
Following this, we washed the microchannel using PBS solution. Next, via the inlet, we 
injected the sample solution, which is a 1:1 mixture of r-Ag and m-Ag (1 μg/mL), and let it 
incubate for 2 minutes. Then we washed the microchannel using PBS solution, whereafter we 
flowed from the inlet the detection Abs solution, which was a 1:1 mixture, of green mouse 
detection Ab and red rabbit detection Ab. Final washing was performed in PBST 0.05%. 
5.2.1.4 Characterization 
For visualization, image acquisition and fluorescence detection of the sandwich immunoassay, 
we used a CCD camera ORCA-C4742-95ER (Hamamatsu, Shizuoka Pref., Japan) mounted on 
 Chapter 5: Microfluidic bio-assays based on self-assembled bead patterns 
 
86 
 
an inverted microscope Axiovert S100 (Zeiss), with a 40x objective (LD Achroplan, numerical 
aperture 0.5). The microscope was equipped with a Mercury short arc lamp HBO (Osram) and 
the appropriate filter set for Cy3 (orange), Alexa Fluor 488 (green), atto488 (green) and Alexa 
Fluor 647 (red) dyes. The exposure time used for capturing the fluorescence signal was 2 
seconds, and AquaCosmos software (Hamamatsu) was used for the fluorescence image 
analysis. Optical microscopy and scanning electron microscopy (SEM) was used to study the 
bead patterning on glass. Optical micrographs were captured using a CCD camera PL-A742 
(PixeLINK, Ottawa, ON, Canada) mounted on a Zeiss Axioskop 2 FS Plus microscope. In the 
case of the stop-flow sandwich immunoassay, the averaged fluorescence intensity profile over a 
75 μm × 75 μm area was obtained from three consecutive bead patterns present at the 
beginning of the line patterns. In the case of the continuous-flow sandwich immunoassay, a 
measurement point corresponds to the fluorescence intensity measured from a single-dot 
pattern present in the middle of the first column. 
5.2.2 Results and discussion 
5.2.2.1 APTES and bead micropatterns 
For the stop-flow immunoassay, the beads were patterned in the form of double lines using 
APTES double line templates (see Chapter 4 under the heading “dynamic-mode patterning”). 
The width of one APTES double line pattern was 5 μm and the distance between two adjacent 
double line patterns was 20 μm. Fig. 5.2a is an optical micrograph showing streptavidin-coated 
 
     
Figure 5.2. Optical micrographs of bead micropatterns (a) in the form of double lines and (b) 
in the form of dots. The insert in (b) is a SEM photograph of beads attached to a single dot. 
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beads patterned in the form of lines on the APTES ridges. In the case of line patterns, we can 
estimate, using optical microscopy, about 70 beads per APTES ridge and thus ~140 beads per 
APTES double line pattern. For the continuous flow immunoassay and for the simultaneous 
detection of two Ags, the beads were patterned in the form of dots using APTES dot templates 
of 2.5 μm diameter (see Chapter 4 under the heading “static-mode patterning”). The pitch 
between the dot patterns in the vertical direction was 15 μm and the thus formed vertical 
columns had a pitch of 7.5 μm. In the case of a dot pattern (see Fig. 5.2b), ~ 4 beads were 
present on average per APTES dot. 
5.2.2.2 Stop-flow immunoassay 
The different steps of the sandwich immunoassay protocol are illustrated in Fig. 5.3, indicating  
the presence of (i) the biotinylated capture Ab, (ii) the target m-Ag, and (iii) the fluorescent 
mouse-detection Ab on the bead surface.  When the immunoassay is performed in the stop-flow 
mode, the sandwich immunocomplex is formed on the bead surface by subsequent filling and 
incubation steps. Diffusion is the only mechanism through which biomolecules in the solution 
can reach the beads. In a 65 μm high microchannel, it takes a maximum of 42 s for the m-Ag 
(diffusion coefficient = 5x10-7 cm2/s1) to diffuse to a bead surface. Therefore, in our assay, we 
used 2 minutes incubation time, resulting in the complete assay time ranging between 17 and 
35 minutes, depending on the total used m-Ag solution volume. 
 
 
Figure 5.3. Schematic illustration of the sandwich immunocomplex formation on the 
streptavidin-coated bead micropattern. The microchannel is filled and incubated, subsequently, 
with biotin-labeled capture antibody (i), target antigen (ii) and Cy3-labeled detection antibody 
(iii), forming the sandwich immunocomplex. 
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After the final washing step, all the beads present in the incubation volume showed comparable 
fluorescence. Fig. 5.4a shows the fluorescence intensity averaged along the direction of the 
bead chains for three consecutive bead line-patterns. These fluorescent profiles correspond to 
the incubation of 1300 nL of target m-Ag solution at different concentrations (0-75 ng/mL). 
The 0 ng/mL intensity profile, taken after an immunoassay protocol without applying target m-
Ag solution, corresponds to the autofluorescence of the beads. Indeed, using bare beads in the  
 
 
Fig. 5.4: (a) Fluorescence signal measured from three consecutive bead patterns after 
performing a full on-chip immunoassay in stop-flow mode using a sample volume of 1300 nL at 
different m-Ag antigen concentrations. (b) Integrated fluorescence obtained from fluorescent 
intensity profiles like shown in Fig. 5.4a for three different volumes of target m-Ag solution 
exposing the bead patterns. 
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microfluidic channel, without having applied the sandwich immunoassay protocol, results in an 
intensity profile that is nearly identical to the 0 ng/mL fluorescent signal, confirming that the 
unspecific adsorption of fluorescent detection Abs is negligible. The total fluorescence 
intensity, corresponding to the immunoresponse of a given target m-Ag concentration, can be 
obtained by integrating the fluorescence intensity profiles, like the ones shown in Fig. 5.4a, and 
subsequently subtracting the bare bead fluorescence intensity. Fig. 5.4b shows the calibration 
curves for the quantification of the target m-Ag for three different sample incubation volumes. 
Each point and error bar correspond to the statistical average and variance over three nominally 
identical immunoassay experiments, respectively. Incubating 1300 nL, 520 nL and 130 nL of 
target m-Ag solution allows to detect target Ag concentrations down to 15 ng/mL, 35 ng/mL 
and 75 ng/mL, respectively. This clearly indicates that, by incubating more target m-Ag 
volume, the detectable concentration is lower. 
 
Given that there are 800 APTES line patterns in the chip’s incubation volume, we can estimate 
a total number of ~112,000 beads exposed during the stop-flow immunoassay. For the three 
incubation volumes used, one finds that the physical detection limit, imposed by our 
fluorescence excitation and detection set-up, corresponds to the presence of about 700 
fluorescent immunocomplexes per bead. For example, using a target Ag concentration of 15 
ng/mL and 1300 nL incubation volume involves in total ~8×107 target m-Ag molecules, 
meaning, on average 700 molecules per bead. These results indicate that a higher assay 
sensitivity is promoted, either by increasing the incubated sample volume, by decreasing the 
number of beads in the incubation volume, or by operating the immunoassay in a continuous- 
flow mode. In the latter case, for the flow rates used, we can hypothesize that the target Ag will 
be captured and concentrated on the bead patterns that are situated most upstream in the flow, 
rather than getting equally distributed over all the beads. 
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5.2.2.3 Continuous-flow immunoassay 
Looking for higher assay sensitivity, we therefore performed the immunoassay experiments in 
the continuous-flow mode. We reduced the number of beads using dot rather than line patterns 
(see Fig. 5.2b and 5.5.). Prior to sandwich immunoassay experiments, we chose to do direct 
immunoassay experiments for the validation of our hypothesis, i.e. for low target Ag 
concentrations, only the beads in the first few columnar arrangements of dots will acquire a 
fluorescence signal, as the target Ag is, by diffusion, gradually gets depleted from the flow 
when passing over subsequent dot columns. 
 
 
Figure 5.5. A representative fluorescent micrograph, showing 10 columns of dot patterns, 
acquired after performing an on-chip direct immunoassay in the continuous-flow mode. 
 
Biotin was chosen as the model antigen for direct immunoassay experiments for two reasons: 
first, it can rapidly and strongly bind to streptavidin and hence the immunocomplex is formed 
in one step and second, it is a very small molecule (mW = 244 Da) when compared with the  
m-Ag (150 kDa) and hence it can diffuse several times faster than the m-Ag.  For example, a 
fluorescently-labeled-biotin molecule, having a mW ~ 831 Da and a diffusion coefficient = 3.4 
× 10-6 cm2/s,2 requires only 6 s to diffuse 60 μm whereas the m-Ag requires 36 s for the same 
distance. This combined effect of strong binding kinetics and a fast diffusion rate is important 
for the (quick) capture of biotin molecules from the flowing sample solution by the first few 
upstream bead patterns. Fig. 5.5 shows a representative fluorescence micrograph of ten 
consecutive columns of bead patterns acquired after the direct immunoassay.  
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Figure 5.6. Fluorescent intensity profile along 150 subsequent single bead-dot patterns after 
performing a direct immunoassay in continuous-flow mode. The first peak and the last peak 
corresponds to the normalized fluorescence of the single dot patterns present in the first and 
the 150th column when counted along the flow direction.  
 
The graph in Fig. 5.6 shows the fluorescence intensity profile acquired from the dot patterns of 
150 consequent columns starting from the most upstream bead pattern. Each intensity peak in 
the graph corresponds to the normalized fluorescence signal measured from a single dot 
pattern. From the graph it is obvious the highest fluorescence intensity signal corresponds to 
the dot pattern present in the first column and thereafter the signal starts to gradually decrease 
until it levels off to the bead autofluorescence level starting from the 140th peak. This shows 
that all the antigens or most of the antigens are captured by the beads of the first 130 columns 
of dots. 
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As the direct immunoassay results were convincing and in line with our previous hypothesis, 
we subsequently performed the sandwich immunoassay experiments in the continuous-flow 
mode for detecting target m-Ag. Fig. 5.7 shows the calibration curve for the target m-Ag 
quantified using the continuous-flow assay protocol by flowing a sample m-Ag volume of 1300 
nL. We are able now to detect the target m-Ag down to a concentration of 250 pg/mL, i.e. we 
achieve a ~60 times higher sensitivity, when compared with the stop-flow assay performance 
for the same 1300 nL incubation volume. 
 
Figure 5.7. The calibration curve for the quantification of m-Ag in a continuous flow 
immunoassay, performed by flowing 1300 nL of m-Ag solution at a flow-rate of 0.25 nL/s. 
5.2.2.4 Assay for simultaneous detection of Two-Ags 
We also used the bead micropatterns as the basis for the simultaneous detection and 
quantification of multiple Ags in a single sample. As a proof-of-concept, we performed the 
detection of two Ag, namely m-Ag and r-Ag, on dot patterns that are realized in the dual 
microfluidic channel structure of Fig. 5.1 (ii). Fig. 5.8a is a fluorescent micrograph of the dot 
pattern in the upper channel of Fig. 5.1 (ii). Here, the dots are grafted with mouse capture Ab 
that specifically binds to target m-Ag from the sample flow. In turn, these captured m-Ags 
specifically react with the mouse detection Ab, giving a green fluorescence signal. Use of the 
appropriate filter set (for the Alexa Fluor 488 dye) on the microscope allows to specifically 
detect the latter signal. When the same dots are visualized with a red filter set (for the Alexa 
Fluor 647 dye) only a weak autofluorescence of the beads is observed, as shown in Fig. 5.8b. 
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Fig. 5.8c is a fluorescent micrograph of the dot pattern in the lower channel of Fig. 5.1 (ii), 
where the dots are grafted with rabbit capture Ab that specifically bind to target r-Ag from the 
sample flow. In turn, these captured r-Ags specifically react only with the rabbit detection Ab,  
 
Figure 5.8. Fluorescent micrographs after performing the assay for the simultaneous detection 
of m-Ag and r-Ag in a dual microfluidic channel structure. (a)  Beads grafted with mouse 
capture Ab bind to the target m-Ag, which, in turn, specifically reacts with the mouse detection 
Ab, giving a fluorescence signal that is observable using a green fluorescence filter set. (b)  
The same beads, when observed using a red fluorescence filter set, do not show a pronounced 
fluorescence signal. (c) Beads grafted with rabbit capture Ab bind to the target r-Ag, which 
specifically reacts with the rabbit detection Ab, giving a fluorescence signal that is observable 
using a red fluorescence filter set. (d)  The same beads, when observed using the green 
fluorescence filter set, do not show a pronounced fluorescence signal. (m(r)-Ag +(-): positive 
(negative) signal for m(r)-Ag detection). Scale bar = 30 μm. 
 
giving a red fluorescence signal. Use of the filter set for the Alexa Fluor 647 dye allows to 
specifically detect the latter signal. When the same dots are visualized with the green filter set 
(for the Alexa Fluor 488 dye) again only a weak autofluorescence of the beads was observed, 
as shown in Fig. 5.8d. These results indicate the high specificity of the antibodies used in the 
immunoassay and demonstrate the two-analyte detection principle in a single chip using the 
bead patterns. In principle, our approach can be extended for detecting multiple Ags, 
simultaneously, by simple extension of the number of microchannels. 
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Finally, it may seem that the magnetic character of the beads that were used is of minor 
importance in these tests, but a major advantage of using magnetic beads is the easy transport 
of the bead solution to the area of interest in a microfluidic channel structure using external 
magnetic fields. Also the magnetic character plays an important role in eventual bead recovery 
for further downstream or off-chip analysis. Preliminary experiments show the possibility to 
release the beads, in a couple of seconds, from the APTES patterns by using a standard 
ultrasonication procedure under application of a flow. Thereafter, there is a possibility to 
capture the released beads by a permanent magnet placed downstream of the microfluidic 
device. 
5.3 Application II: Cell-based assay 
5.3.1 Experimental 
5.3.1.1 Chemicals and Materials 
The 5D10 mAb was purchased from the University of Hasselt, Biomedical Research Institute, 
Diepenbeek, Belgium and it was biotinylated using the ImmunoprobeTM Biotinylation Kit 
(BK101, Sigma) according to the manufacturer’s instructions. Biotinylated anti-mycoplasma 
(product no. 11296744) was purchased from Roche. Eu-W8044 luminescent complex was 
purchased from PerkinElmer Life and Analytical Sciences, Turku, Finland. 5D10 mAb was 
labeled with Eu-W8044 according to the protocol published by Mukkala et al.3 Fibronectin 
(FN) (F1141) and glutaraldehyde (GA) (product no. G7526) were purchased from Sigma. ER-
TrackerTM Blue-white DPX (ER-Tracker) (product no. E12353) was purchased from 
Invitrogen. Different antibody and protein dilutions were done in PBS. The negative photoresist 
SU8-50 and the positive photoresist AZ1512 were purchased from Microchem Corp. (MA, 
USA) and Shipley Europe Ltd. (Cheshire, UK), respectively. Poly-(dimethylsiloxane) (PDMS) 
pre-polymer and curing agent (Sylgard 184) were purchased from Dow Corning (MI, USA). 
Float glass wafers (Ø 4 in.) and deionized (DI) water of resistivity 18.2 MΩ-cm were obtained 
from EPFL’s Center of Micro- and Nanotechnology. 
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5.3.1.2 Cell lines and cell culture 
The human breast adenocarcinoma cell line MCF-7 (ATCC HTB-22) and human leukemia cell line 
Jurkat (ATCC TIB 152) were cultivated in 75 cm2 culture flasks using RPMI 1640 (Sigma, R8758, 
UK) supplemented with 5% fetal calf serum (FCS), 2 mM L-glutamine, 1 mM sodium pyruvate, 
1% non-essential amino-acids, 1% 4-(2-hydroxyethyl)- monosodium salt (HEPES) (all from Gibco® 
Cell Culture, Invitrogen, Basel, Switzerland). Cultures were maintained at 37 °C under 5% CO2. 
The growth medium was changed every other day until the time of use of the cells. Cell density and 
viability, defined as the ratio of the number of viable cells over the total number of cells, of the 
cultures were determined using trypan blue staining and a Neubauer improved hemacytometer 
(Blau Brand, Wertheim, Germany). For studying the specificity of the target cell separation, a cell 
solution was prepared by mixing MCF-7 cells (concentration 1×106 cells/ml), which were stained 
using 1 μM of ER-tracker at 37°C and 5% CO2 for 1 h prior to their trypsinization, with non-
stained Jurkat cells (concentration 1×106 cells/ml) in a 40:60 ratio. For experiments involving cell 
capture, followed by culture and 5D10 biomarker-based immuno-fluorescence detection, we used a 
cell mixture where both MCF7 and Jurkat cells were non-stained. 
5.3.1.3 Assay protocol 
The microfluidic chip (see section 5.2.2 for details on chip fabrication and assembly) was 
mounted on a microscope set-up and a neMESYS syringe pump (Cetoni GmbH, Germany) was 
used for flowing the bead, cell-mixture, reagent and washing solutions through the 
microchannel. All the reagent solutions were filled and incubated in the stop-flow mode, i.e. 
filling was done in an incremental fashion comprised of 5 filling steps, and after each filling step 
incubation was done for a minute. The microfluidic channel had a width of 200 μm, a height of 
100 μm and a total length of 25 mm. Beads were patterned in situ inside the microchannel by 
filling and incubating 5× diluted bead solution for about 30 s under the presence of a magnetic 
field. During the incubation steps, a permanent magnet was placed and moved slowly beneath the 
channel. Then the excess bead solution was washed in PBST, resulting in the situation illustrated in 
Fig. 5.9a. Following this, the beads were coated with either biotinylated 5D10 mAb and 
biotinylated FN by filling and incubating a 1:1 mixture solution of these two proteins (each of 50 
μg/ml concentration) inside the channel volume. For performing negative-control experiments, in 
the above mentioned mixture, biotinylated 5D10 mAb solution was replaced by biotinylated anti-
mycoplasma solution. After this, the channel was washed by flowing a PBS solution for 2 minutes  
 Chapter 5: Microfluidic bio-assays based on self-assembled bead patterns 
 
96 
 
 
 
Figure 5.9. Schematic illustration showing the concept of specific capture from a cell mixture 
of MCF-7 cells on self-assembled beads micropatterned in situ inside a microfluidic channel, 
followed by subsequent culture. (a) Streptavidin-coated beads are first self-assembled in situ on 
amino(propyl)triethoxysilane micropatterns inside the microchannel. (b) Biotinylated 5D10 
mAb and biotinylated fibronectin are grafted on the bead surface. (c) A cell solution containing 
both MCF-7 and Jurkat cells is incubated with the beads. (d) After washing, only MCF-7 cells 
are immuno-specifically captured/retained by the beads. (e) MCF-7 cells adhere and grow on 
top of the beads aided by the fibronectin. (f) After a few hours of cell culture, the 5D10 
biomarker on the MCF-7 cell surface is detected using luminescently labeled 5D10 mAb. 
 
resulting in the situation shown in Fig. 5.9b. The flow-rate used for applying the reagents, cell-
mixture and washing solutions was 10 nL/s, unless otherwise specified. For determining the cell 
capture efficiency, the MCF-7 target and the Jurkat negative-control cell solutions were separately 
filled inside two different channels and incubated for a minute. In order to facilitate the capture of 
the cells by the micro-patterned beads, 50 nL of the incubated cell solution was displaced back and 
forth at a flow rate of 2 nL/s. Cell capture efficiency was determined by counting the total number 
of MCF-7 and Jurkat cells in the microfluidic channel volume both before and after washing. 
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In order to demonstrate the selective capture of target cells mixed with negative-control cells, the 
channel volume was filled with the cell mixture (see Fig. 5.9c) and incubated for a minute, during 
which 50 nL of the cell solution was displaced back and forth at a flow-rate of 2 nL/s. Thereafter 
washing was performed in PBS (see Fig. 5.9d), after which the captured MCF-7 cells were cultured 
for 4 hours resulting in their adhesion and growth (see Fig. 5.9e).  After incubating the cultured 
cells with 5% GA diluted in PBS during 2 minutes, they were, for luminescent 
immunocytochemical analysis, incubated with Eu-W8044-labeled 5D10 mAb (50 μg/mL) for 2 
minutes, followed by a final washing step in PBS (see Fig. 5.9f). 
5.3.1.4 Characterization 
For visualization, image acquisition and fluorescence detection of the cells, we used a CCD 
camera ORCA-C4742-95ER (Hamamatsu, Japan) mounted on an inverted microscope Axiovert 
S100 (Zeiss), with a 10x objective (Achroplan, numerical aperture 0.5, Ph1). The microscope 
was equipped with a Mercury short arc lamp HBO (Osram) and the appropriate filter set for 
ER-TrackerTM dyes. The exposure time used for capturing the fluorescence signal was 10 
seconds, and Zeiss Axio-Vision software was used for the luminescence image analysis. 
Optical micrographs were captured using a CCD camera PL-A742 (PixeLINK, USA) mounted 
on a Zeiss Axioskop 2 FS Plus microscope. For cell immune-luminescence detection, we used a 
home-modified Wallac Signifier time-resolved (TR) luminescence microscope from 
PerkinElmer Analytical and Life Sciences. The TR  luminescence microscope consists of a 
conventional fluorescence microscope, Nikon Eclipse E600 coupled with a time-resolved work 
station4. The following measurement conditions were used for the detection of Eu; excitation: 
bandpass filter 340 (BP 70 nm); emission: longpass filter (LP) 420 nm; excitation pulse length: 
10 µs; delay time: 100 µs; gate time: 600 µs; exposure time: 60 s. 
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5.3.2 Results and discussion 
5.3.2.1 Bead Patterns 
Streptavidin-coated beads were patterned in the form of 5 μm dots within 50 μm wide stripes 
and the pitch between the adjacent stripes was 40 μm (see Fig. 5.10). Thanks to the magnetic 
property of beads, we used an external permanent magnet to accelerate the self-assembly 
process. The total self-assembly process may take about 5 minutes if no magnetic field is 
applied, however, with the application of a magnetic field it takes place in a matter of seconds. 
5.3.2.2 On-chip MCF-7 target cell separation  
The specific separation ability of the beads has been tested on a mixture of MCF-7 and Jurkat 
cells which were introduced into the microfluidic channel and incubated. A fluorescent 
microscopy image superimposed onto the bright field micrograph clearly shows the mixture of 
MCF7 stained with the ER-TrackerTM tracker and non-stained Jurkat cells during incubation 
after a single microfluidic channel filling step (Fig. 5.10a-c). After washing, the same 
microscopy experiments solely evidenced the presence of MCF-7 cells immobilized on the 
beads (Fig. 5.10d-f). This unambiguously proves that only MCF-7 cells were selectively 
captured and that no Jurkat cells stick to the beads after washing. The specificity of the target 
cell capture was further evidenced by using the non-specific mycoplasma mAb grafted on the 
patterned beads. In these negative-control experiments, none of incubated cells were seen 
sticking to the beads as both MCF-7 and Jurkat cells do not express mycoplasma antigens on 
their surface. Though the system was not optimized for capture efficiency, the incubated MCF-
7 cells could be selectively captured with a yield of 85 ± 10%.  
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Figure 5.10. Bright field optical and fluorescent visualization of the cells before (a-c) and after 
(d-f) washing. (a) Bright field micrograph of the MCF-7 and Jurkat cell mixture during 
incubation. (b) Fluorescent micrograph showing ER-TrackerTM stained MCF-7 cells. (c) 
Merged image of (a) and (b). (d) Bright field micrograph of the captured MCF-7 cells after 
washing resulting in the removal of the Jurkat cells. (e) Fluorescent micrograph showing the 
ER stained MCF-7 cells. (f) Merged image of (d) and (e). 
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5.3.2.3 Cell culture and time-resolved luminescence detection 
Following selective capture and separation on the magnetic beads, the MCF-7 cells were 
cultured during 4 hours under standard conditions and detected by means of an 
immunocytochemical analysis of the 5D10 biomarkers expressed on their membrane surface. 
For this experiment, the cells were incubated in presence of the specific 5D10 mAb labeled 
with the lanthanide luminescent probe Eu-W8044. This allowed to detect the EuIII 
luminescence in time-resolved mode, with a time delay of 0.1 ms, enhancing the signal-to-noise 
ratio. Fig. 5.11a shows a bright-field image of the MCF-7 cells cultured on top of the bead 
patterns. After 4 hours of culture, we could clearly observe the epithelial cell shape – compared 
to the round shape in Fig. 5.10 – of the MCF-7 cells, which reflects the adhesion of the cells on 
the FN-coated beads. Fig. 5.11b displays the corresponding TR luminescence after incubation 
with the Eu-labeled 5D10 mAb. The presence and detection of the 5D10 biomarker on the cell 
surface is thereby clearly demonstrated. Moreover, the background luminescence due to the 
autofluorescence of the immobilized cells and of the PDMS-based device could be completely 
eliminated in the TR detection mode.5  
 
 
 
Figure 5.11. (a) Bright field image showing MCF-7 cells that were captured and cultured (for 
4 hours) on the patterned beads inside a microfluidic channel. (b) The TR luminescence image 
corresponding to (a) shows the presence of 5D10 antigens on the surface of the MCF-7 cells. 
(Scale bar: 40 μm) 
 
Fig. 5.12a is a high resolution picture showing the typical MCF-7 cell shape after culture on the 
bead patterns, which is comparable with the morphology of the cells grown on plastic wells 
(Fig. 5.12b). 
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Figure 5.12. Morphology of MCF-7 cells after an over-night culture (a) in-situ inside a 
microfluidic channel on top of the bead patterns and (b) in a conventional cell culture well. 
(Scale bar: 40 μm) 
 
 
 
 
Figure 5.13. Snapshots of a movie demonstrating the removal of captured target cells using an 
air-bubble introduced inside the microfluidic channel. (a) The bubble is approaching the 
captured cells, (b) passes over the captured cells and strips them off the bead surface, leaving 
(c) bare beads without cells attached.  
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Conventional detachment of the MCF-7 cells after culture was not possible, even after treating 
the cells with a trypsin solution for more than an hour. The strong cell adherence probably 
arises from the combined effect of cell-bead binding forces contributed by both the fibronectin 
and the 5D10 mAb. On the other hand, it was possible to detach the cells by introducing an air 
bubble in the microfluidic channel6 due to interfacial forces (see Fig. 5.13). The thus stripped-
off cells can be collected at the chip outlet for further analysis or can be transported to other 
parts of the microfluidic chip. 
5.4 Conclusion 
In the first half of this chapter we have demonstrated complete microfluidic immunoassays 
using streptavidin-coated magnetic beads as substrate. The ridges of APTES micro-patterns are 
used as the template for bead self-assembly. We used both mouse IgG (m-Ag) and rabbit IgG 
(r-Ag) diluted in phosphate buffered saline (PBS) with 1% bovine serum albumin (BSA) 
solution as target. The fluorescent sandwich immunocomplex was formed on the beads during 
the operation of the chip both in stop-flow and continuous flow mode. Target m- Ag was 
detected down to a concentration of 15 ng/mL in the stop-flow mode and 250 pg/mL in the 
continuous flow mode, using 1300 nL of sample volume. Our results indicate that a higher 
assay sensitivity can be achieved, either by increasing the incubated sample volume, by 
decreasing the number of beads in the incubation volume, or by operating the immunoassay in 
a continuous flow mode. In the latter case, the target m-Ag is concentrated on the bead patterns 
that are situated more upstream in the flow, rather than getting equally distributed over all the 
beads, as is the case for the stop-flow assay. We have also demonstrated that m-Ag and r-Ag 
can be simultaneously detected in a single assay by realizing a dual microfluidic channel 
structure with properly functionalized bead patterns. Thanks to the simple bead patterning 
approach and the possibility to functionalize dedicated bead patterns in a complex microfluidic 
manifold microstructure, we expect that our approach holds large potential for more complex 
multi-analyte bioassays on-chip. 
 
In the second half of this chapter we have presented a microfluidic chip-based specific 
separation of MCF-7 epithelial breast cancer cells from a mixed cell solution using 
functionalized beads, followed by culture, and immunocytochemical analysis by time-resolved 
luminescence of a Eu-labeled 5D10 mAb. One of the advantages of this approach is the short 
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time required for micropatterning the beads inside a microchannel using our magnetic-field 
assisted electrostatic self-assembly technique. The second advantage lies in the bead lending 
itself to all classical techniques required for live cell targeting and subsequent culture based on 
the grafting of immuno-specific cell-capture ligands and cell-adhesion promoting proteins. The 
captured cells adhere and grow on the bead surface in a normal way, displaying an adequate 
morphology. Finally, decoration of the specific 5D10 monoclonal antibody with a lanthanide 
luminescent probe leads to improved immunocytochemical analysis of the cultured cells. We 
believe that this integrated approach of cell capture in (patterned) areas of interest followed by 
their short-term culture and analysis on a single zone of a microfluidic chip, based on in situ 
self-assembled pre-functionalized beads can open doors for easier and quicker realization of 
bead-based labs-on-a-chip devices for cellomics studies. In addition, we are convinced that the 
magnetic field-assisted patterning approach will prove particularly useful for other applications, 
where one needs to rapidly and densely self-assemble nanometer-size magnetic beads on a 
substrate, which otherwise would take several tens of minutes by sedimentation. 
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6.1 Introduction 
The development of miniaturized bio-analytical systems is an ever-growing field of research1-3, 
particularly in medical diagnostics as proposed recently for HIV/AIDS4 or for the 
characterization of predictive biomarkers in malignant tumors and the follow-up of the disease 
during treatment5. On the other hand, autofluorescence of the polymeric materials used for the 
fabrication of microfluidic devices6-8, e.g. biocompatible polydimethylsiloxane PDMS (see Fig. 
6.1), may prevent fluorescence detection of commonly used organic markers such as 
tetramethylrhodamine isothiocyanate, fluorescein isothiocyanate (FITC), or Cy3, and hence 
presents a limiting factor to the development of multiplex bioassays9. Moreover, when a chip is 
loaded with cells or tissue, their autofluorescence, either intrinsic or induced by fixation media 
and/or tissue processing, may mask specific fluorescent signals or be misinterpreted as specific 
labels, thus creating false positive read-outs10. This limitation can be overcome by replacing 
organic fluorescent labels with lanthanide luminescent bioprobes (LLBs), the features of which 
are well documented11.  
 
Figure 6.1: (a) Fluorescence spectrum of PDMS used for fabricating microfluidic devices. The 
graph shows that the PDMS emits considerable autofluorescence signal under excitation 
wavelengths used for common organic fluorescent labels like FITC. The diagonal black bar 
corresponds to saturation of the detector (> 65,000 counts) by the excitation signal. (From 
reference9) 
 
The benefits of LLBs are: (i) easily recognizable line-like emission spectrum (ii) long excited-
state lifetimes (upto several milliseconds) allowing the use of time-resolved measurements 
leading to very low detection limits (10-14-10-16 M), because background signals and sample 
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autofluorescence are eliminated and (iii) large stokes shifts upon ligand excitation. LLBs are 
therefore emerging as viable alternatives to existing organic dyes in immunoassays12, for DNA 
detection13 or various intracellular analytes14. 
 
The new methodology, for which a proof-of-concept is given in this work, combines the 
advantages of PDMS microfluidics with LLB technology. In fact, we show how it can reliably 
detect cancer bio-markers on breast cancer cells, as well as on breast cancer tissue sections. 
This approach takes advantage of time-resolved luminescent imaging of individual tumor cells 
and features fast assay analysis times (< 20 min) and low reagent consumption (μL volumes). 
 
This chapter is an adapted version of the following journal articles: 
• V. Sivagnanam*, B. Song*, C. Vandevyver, I. Hemmilä, H-A Lehr, M. A. M. Gijs and 
J-C. G. Bünzli, Time-resolved lanthanide luminescence for lab-on-a-chip detection of 
biomarkers on cancerous tissues. Analyst, 2009, Vol. 134, pg. 1991-1993. (*These 
authors contributed equally to this article) 
 
• V. Fernandez-Moreira, B. Song, V. Sivagnanam, A-S. Chauvin, C. Vandevyver, M. A. 
M. Gijs, I. Hemmilä, H-A Lehr, and J-C. G. Bünzli, Bioconjugated lanthanide 
luminescent helicates as multilabels for lab-on-a-chip detection of cancer biomarkers. 
Analyst, 2010, Vol. 135, pg. 42-50. 
 
 
6.2 Background 
6.2.1 Immunoassays 
Given the number of patients suffering from breast cancer, we concentrate in this paper on the 
targeting of the human breast adenocarcinoma cell line MCF-7 and of biomarkers expressed by 
breast cancer tissues. We demonstrate that the proposed LLB-on-chip technology reliably 
detects a mucin-like antigen (Ag) expressed on MCF-7 cells, as well as estrogen receptor (ER), 
human epidermal growth factor receptors 2 (Her2/neu) and progesterone receptor (PR) on 
formalin-fixed breast cancer tissues. Depending on the targeted bio-marker, two types of 
analyses can be made, either an immunocytochemical assay or an immunohistochemical assay 
(Fig. 6.2).  
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6.2.2 Time-resolved microscopy 
A schematic illustration of a TR microscope system is shown in Fig. 6.3. A TR microscope is a 
conventional fluorescent microscope fitted with additional components (a mechanical chopper, 
a chopper controller and a Xenon flash lamp) to aid TR resolved imaging. For TR imaging, a 
xenon flash lamp, controlled via a pulse/frequency controller, is used as the sample excitation 
                                         
 
Figure 6.3. Schematic illustration of a time-resolve microscope. 
 
 
source. The excitation wavelength is selected using an appropriate emission filter set.        
imaging, a xenon flash lamp, controlled via a pulse/frequency controller, is used as the sample 
excitation source. The excitation wavelength is selected using an appropriate emission filter set. 
The fluorescence/luminescence signal emitted from the sample, after a short pre-set time delay 
(typically a few hundred μs), is gated to the CCD camera for a defined interval by 
operating/opening a computer-controlled mechanical chopper. This pre-set time delay plays the 
vital role of gating-out, i.e. eliminating the background and sample autofluorescence or noise 
that is usually short-lived (well within the pre-set delay time). On the contrary, as the 
luminescence signal is long-lasting, the same can be gated-in to the camera after the time delay. 
The desired emission wavelength is selected using an appropriate emission filter sets. The same 
microscope set-up can be used for conventional fluorescent imaging by selecting the Mercury 
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arc lamp as the light source (via the dual port) and by switching the mechanical chopper to its 
stand-by open position. 
 
The operation/control sequence involved in the time-resolved long-lived luminescence imaging 
is illustrated by the Fig. 6.4. First the excitation light-pulse (tex1-tex2, green) is exposing the 
sample, resulting in an emitted luminescence signal (blue). After a time delay of td, the emitted 
signal is gated-in to the CCD camera during the time frame tg2-tg1 (red). The CCD camera 
controller integrates the signal and communicates the resulting data to PC for storage and 
image generation. 
 
 
Figure 6.4. A schematic illustration of the control sequence used for time-resolved 
luminescence imaging  
 
6.3 Experimental 
6.3.1 Reagents 
Eu-W8044 and Tb-W14016 luminescent complexes (see Figure 6.5) were from PerkinElmer 
Human Health, Turku, Finland. The 5D10 mAb was purchased from the University of Hasselt, 
Biomedical Research Institute, Diepenbeek, Belgium. Avidin (A9275), fibronectin (FN) 
(F1141), poly-l-lysine (P4832) and anti-mouse IgG produced in goat (M8645) were purchased 
from Sigma. FITC-conjugated streptavidin (19538-050) and 4',6-diamidino-2-phenylindole 
(DAPI, D1306) were obtained from Invitrogen. Biotin-conjugated anti-mycoplasma 
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(11296744) was purchased from Roche. Biotin-conjugated Substance P was obtained from the 
Department of Biochemistry, University of Lausanne, Switzerland. The monoclonal antibody 
5D10 was biotinylated using the ImmunoprobeTM Biotinylation Kit (BK101, Sigma) according 
to the manufactures instructions. Polyclonal rabbit anti-human c-erbB-2(Her2) oncoprotein (A 
0485), monoclonal mouse anti-human PR (M3569) and biotinylated anti-IgG (K0679) were 
purchased from DAKO. Anti-human ER mouse monoclonal antibody (RTU-ER-6F11) was 
obtained from Novocastra Lab Ltd.  
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Figure 6.5. Formulae of the Eu-W8044 (left) and Tb-14016 (right) chelates 
 
6.3.2 Cell lines and culture conditions 
We used the following cell lines: human cervical adenocarcinoma cell line HeLa (ATCC CCL-
2) and human breast adenocarcinoma cell line MCF-7 (ATCC HTB-22). Cells were cultivated 
in 75 cm2 culture flasks using RPMI 1640 (Sigma, R8758, UK) supplemented with 5 % fetal 
calf serum (FCS), 2 mM L-glutamine, 1 mM sodium pyruvate, 1 % non-essential amino-acids, 
1 % 4-(2-hydroxyethyl)- monosodium salt (HEPES) (all from Gibco Cell Culture, Invitrogen, 
Basel, Switzerland). Cultures were maintained at 37 °C under 5 % CO2 and 95 % air 
atmosphere. The growth medium was changed every other day until the luminescent 
experiments. Cell density and viability, defined as the ratio of the number of viable cells over 
the total number of cells, of the cultures were determined using trypan blue staining and a 
Neubauer improved hemacytometer (Blau Brand, Wertheim, Germany). 
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6.3.3 Lanthanide labeling of proteins 
Lanthanide-labeled avidin, 5D10 mAb, anti-mouse IgG Ab and anti-rabbit IgG Ab were 
prepared according to the protocol by Mukkala et al.20 e.g., 1 mg of anti-mouse IgG Ab and 20-
fold excess of Ln complex (124 nM) were mixed in 200 μl of 0.1 M sodium carbonate solution 
(pH 9.3), and incubated overnight at 4 0C. The Ln-labeled anti-mouse IgG Ab was purified by a 
Sephadex G25 column (354678, GE healthcare) and eluted with PBS. The complex:protein 
ratio was determined by a DELFIA assay (DELFIA® Inducer and DELFIA Enhancer, 
PerkinElmer Human Health, Wallac Oy, Turku, Finland). 
6.3.4 Microfluidic chip 
Both immunocytochemical and immunohistochemical assays were carried out in-situ inside a 
microfluidic channel. Straight microfluidic channels, with length, width and height of 20 mm, 
200 μm and 100 μm, respectively, were used for immunocytochemical assays (Fig. 6.6 a(i)). 
 
 
 
Figure 6.6. Top views (i) and cross-sectional views (ii-iii) of the microfluidic channel used for 
the immunocytochemical assay (a) and the immunohistochemical assay (b) 
 
The microfluidic chip is realized by irreversibly bonding the PDMS microchannel replica, 
having the inlet and outlet access holes, with a float glass substrate (20 mm X 60 mm). The 
PDMS replica and the glass substrate were subjected to air plasma (500 W, 4 mbar) for 20 s 
and then immediately brought into contact, resulting in permanent sealing (Fig. 6.6 a(ii)). 
Thereafter the microchannel surface was coated with appropriate proteins for promoting cell 
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adhesion and subsequently cells for the assays were seeded and cultured inside the 
microchannel (Fig. 6.6 a(iii)) (see section 6.3.3).  
 
For the immunohistochemical assays a serpentine channel design was used as shown in Fig 6.6 
b(i). When compared to a straight microfluidic channel, the serpentine channel structure 
provide a better coverage and access to the cancerous areas that are randomly located amidst 
normal cells on the biopsied tissue section/slice. Though a straight microfluidic channel with a 
larger width, which is comparable to the width of the biopsied tissue section, can be used as an 
alternative to serpentine microchannels, it has to be noted that, in the case of former the total 
channel volume will be relatively higher than in the latter case and thus resulting in the 
consumption of more reagent volume and also more time for implementing the assay protocol. 
The length, width and height of the serpentine channel is 20 mm, 200 μm and 100 μm, 
respectively, and the wavelength of the serpentine structure is 900 μm. Unlike the case of the 
immunocytochemical assay, here the microfluidic chip is fabricated by reversibly sealing the 
PDMS replica against the glass substrate bearing the tissue section (Fig 6.6 b (ii-iii)). 
6.3.5 Immunocytochemical assay protocol 
Prior to cell loading, microchannels were subjected to UV light exposure for 10 min to remove 
potential bacterial contamination, and were then incubated with 80 μg/mL cell-adhesion 
promoting protein FN for 15 min at room temperature. After washing the coated microchannels 
with phosphate buffered saline (PBS), cells were pumped into the microchannels and the device 
was incubated overnight at 37 °C under 5% CO2. The cells grown in the microchannels were 
then fixed with 2% glutaraldehyde for 5 min. at room temperature. After washing with PBS, the 
microchannels were incubated for 5 min. with a blocking buffer (1% casein hydrolysate and 
0.05% Tween-20 in PBS).  For the indirect immunocytochemical assay, the microchannels 
were incubated for 5 min at room temperature with the primary antibody - biotin-conjugated 
5D10 mAb - diluted in the blocking buffer. The microchannels were subsequently washed 2x1 
min (flow rate: 50 nL/s) with PBST (PBS with 0.05 % Tween-20) and incubated for 6 min after 
flowing Eu-W8044-labeled avidin or FITC-conjugated streptavidin diluted in the blocking 
buffer for 2x1 min (50 μg/mL, flow rate: 50 nL/s). For the direct immunocytochemical assay, 
the microchannels were incubated for 5 min at room temperature with the primary antibody – 
Ln-complex coupled 5D10 mAb - diluted in the blocking buffer. Finally, the microchannels 
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were washed with PBST and immunostaining was evaluated with a Nikon Eclipse E600 
luminescence microscope equipped with the appropriate facility for time-resolved imaging. 
6.3.6 Immunohistochemical assay protocol 
Three breast tissue samples were obtained from paraffin slides of formalin fixed tumor tissues 
(see Fig. 6.7) archived in the routine diagnostic laboratory of the Institute of Pathology of 
CHUV. Samples were evaluated for prior hormone receptor and Her2/neu expression by the 
pathologist involved in this study and transferred to the EPFL laboratory in a non-identified, 
coded fashion according to published procedures21 and standard guidelines. The tissues were 
dewaxed in 100% xylene (10 min) and then rapidly rehydrated successively in 100%, 95%, 
70%, and 40% ethanol. After heat-induced antigen retrieval in sodium citrate buffer (S1700, 
DAKO) using a water bath (95-99 oC, 30 min), the tissue sections were sealed to the PDMS 
microchannel as discussed before and, thereafter, the tissue section was washed by flowing 
with Tris-HCl buffer pH 7.6 (TBS) for 2 min. 
 
 
Figure 6.7. A representative photograph of a glass slide with a formalin-fixed tissue slice 
biopsied from a breast cancer patient. 
 
For performing single detection, the tissue is incubated with the primary antibody (non-diluted 
anti-human ER mouse mAb or a 1/400 dilution of polyclonal rabbit anti-human c-erbB-
2(Her2/neu) oncoprotein Ab or a 1/50 dilution of anti-human PR mouse mAb), at room 
temperature for 3x2 min. After washing with TBS (30 s), the detection antibody was added at 
room temperature for 6 min. For ER, or PR detection, 50 μg.mL-1 Eu-W8044-labeled anti-
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mouse IgG was used and for Her2/neu detection, Eu-W8044-labeled anti-rabbit IgG was used. 
Finally, tissue sections were incubated with 3 μM DAPI at room temperature for 2 min. and 
washed with TBS for 30 s before TR detection of the immunoluminescence.  
For performing dual detection of ER/PR and Her2/neu, initially the tissue was incubated with 
the appropriate mixture of primary antibodies, i.e. non-diluted anti-human ER mouse mAb or a 
1/50 dilution of anti-human PR mouse mAb and a 1/400 dilution of polyclonal rabbit anti-
human c-erbB-2(Her2/neu) oncoprotein Ab, for 3x2 min. After washing with TBS (30 s), the 
tissue was incubated with the appropriate mixture of detection antibodies, i.e. at room 
temperature for 3x2 min. For all immunohistochemical assays, we used a flow rate of 100 nL/s 
to fill and/or flow the reagents and washing solutions inside the microfluidic channel. 
6.3.7 Microscopy parameters 
For the immunocytochemical assay, the following settings were used for single detection of Eu-
W8044: excitation: 340 nm (band pass (BP) 70 nm); emission: long pass filter (LP) 420 nm; 
excitation pulse length: 10 µs; delay time: 100 µs; gate time: 600 µs; exposure time: 30 s. For 
multiplex detection:  Eu- W8044: excitation: 340 nm (BP 70 nm); emission: LP 585 nm; for 
Tb- W14016: excitation: 340 nm (BP 70 nm); emission: 545 nm (BP 35 nm). The fluorescence 
of FITC was recorded using classical fluorescent microscopy (excitation: 480 nm (BP 30 nm) 
filter, emission: 530 nm (BP 30 nm) filter, exposure time: 10 s). The time-resolved 
measurement conditions for the immunohistochemical assay were as described above, except 
for the exposure time, which was 60 s. The fluorescence of DAPI was collected with 
conventional fluorescence microscopy (excitation: 365 nm (BP 80 nm) filter, emission: 450 nm 
(BP 65 nm) filter, exposure time: 5 s). 
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6.4 Results 
6.4.1 Cell culture in microchannels 
Prior to cell loading, the microfluidic channels were coated with a cell adhesion protein, poly-
L-lysine (PLL) or a major integrin ligand, fibronectin (FN)22, as the PDMS and glass-based 
microfluidic device does not provide good adhesion conditions for epithelial cells. The choice 
of the coated cell-adhesion-protein depends on the cell type. For instance, MCF-7 cells seeded 
in FN- and PLL-coated microchannels did adhere and grow in an epithelial monolayer, while 
this was not the case for uncoated channels; on the other hand, HeLa cells grew only as 
epithelial monolayer in FN-coated microchannels (Figure 6.8). 
 
Figure 6.8. Bright field images of HeLa (upper row) and MCF-7 (lower row) cells seeded 
during 24 h in (a) uncoated, (b) PLL-coated or (c) FN-coated 200 µm wide microchannels. 
The experimental parameters pertaining to cell culture into the microchannels have been 
carefully optimized. Firstly, with respect to the concentration of FN, the number of adherent 
cells (NAD) was found to depend linearly on FN concentration up to ≈ 60 µg/mL and then to 
level off (Figure 6.9a). As a consequence, a FN concentration of 80 µg/mL was chosen. 
Secondly, the coating time of FN was set to 15 min since the NAD does not increase with 
increased time (Figure 6.9 b). Thirdly, the optimum cell seeding time was determined. A cell 
solution (1×106 cells/mL) was injected into the microchannel and incubated for times ranging 
from 0.5 to 6 h. Thereafter, excess of non-adherent cells were washed out with a phosphate 
50 μm
HeLa
MCF-7
a b c
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buffer saline (PBS) solution at a flow rate of 100 nL/s. We observed an increase in NAD with 
increasing cell incubation periods (Figure 6.9 c). After 0.5 h, MCF-7 cells began to adhere to 
the surface of the FN-coated channel and then cells spread: many pseudo-pods were formed, 
the cell fringes enlarged and their area increased. Compared to MCF-7 cells, HeLa cells grew 
faster and already 15 min after seeding, cells began to adhere and spread. Furthermore, 
increasing the seeding time to 2h did not result in increased cell adhesion, but the cells did not 
have the right morphology, namely an epithelial monolayer, for incubation times < 2 h. 
Therefore, for all subsequent experiments, a cell seeding time larger than 8 h was adopted. 
Finally, cell seeding density was also examined (Figure 6.9 d), since highly concentrated 
solutions of cells can overpopulate and prevent proper cell attachment onto the walls of the 
microchannels. Collected data showed that a concentration of 2×106 cells/mL provides an 
adequate number of cells without leading to multilayer growth. 
 
Figure 6.9. MCF-7 and HeLa epithelial cell adhesion study in a microchannel. The average 
number of cells are counted in an area of 2.5 mm2 of the microchannel as a function of (a) FN 
concentration (FN coating = 2 h, cell seeding time = 8 h, cell density = 1×106 cells/mL), (b) 
FN coating time, ([FN] = 80 µg/mL, same cell seeding time and cell density as for a), (c) cell 
seeding time ([FN] = 80 µg/mL, FN coating time = 15 min, cell density = 1×106 cells/mL), and 
(d) the cell seeding density ([FN] and FN coating time as in c), seeding time = 8h). 
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Figure 6.11. Relative luminescence intensity as a function of the 5D10 mAb concentration 
using Eu-W8044-labeled avidin or FITC-labeled streptavidin as the secondary 
immunocytochemical detection system. 
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For the dual detection, we take advantage of the spectral versatility brought by two different 
lanthanide labels, the red emitting Eu-W8044 chelate (used previously) and the green-emitting 
Tb-W14016 probe (life-time = 1.18 s, quantum yield = 8.4%). The on-chip dual detection assay 
was performed as follows: for the detection of the Ag recognized by the 5D10 mAb, MCF-7 
cells were incubated with the Eu-W8044-labeled 5D10 mAb (direct assay), while for 
evidencing the Substance P receptor, the cells were incubated with a biotinylated Substance P 
peptide, followed by incubation with Tb-W14016-labeled avidin (indirect assay). 
Immunoreactivity was evaluated with time-resolved luminescence microscopy using the 
appropriate emission filters for spectral discrimination. As shown in Fig. 6.13, the Ag for 5D10 
mAb was detected by the red label Eu-W8044 (Fig. 6.13 b) and Substance Preceptor by the 
green label Tb-W14016 (Fig. 6.13 c). These results clearly indicate the possibility of 
multiplexed on-chip immunocytochemical detection of several antigens, at the same time, 
taking advantage of the lanthanide labels with distinct emission spectra. 
 6.4.3 Immunohistochemical detection 
Single biomarker detection on cancerous tissues 
Having demonstrated the feasibility of our approach for the detection of antigens expressed by 
cells grown in microchannels, we subsequently turned to the analysis of prognostic biomarkers 
on human tumor tissues. We performed separate detection of three prognostic biomarkers, viz. 
ER, PR and Her2/neu. The detection of each of these three biomarkers was carried out on five 
different breast-cancer tissue samples obtained from the clinical laboratory. As shown in Fig. 
6.14, the tissular expression of all these three biomarkers was detected with the microfluidic 
devices coupled with lanthanide label technology. ER and PR are located in the nuclear 
membranes of the tumor cells whereas the Her2/neu is expressed on the tumor cell surface and 
the specific staining is clearly evidenced in the merged images corresponding to the tissue 
sample A (positive samples) displayed in the top, middle and bottom panels, respectively. The 
results of the immunohistochemical detection from all the five different tissue samples, for all 
the three different biomarkers is summarized in the Table 6.2. The results were in complete 
agreement with those obtained in the clinical laboratory using classical immunohistochemical  
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7.1 Summary of the thesis results 
We have demonstrated a simple and fast method for self-assembly-based micropatterning of 
protein-functionalized magnetic beads on glass. We used positively-charged aminosilane 
(APTES) micro-patterns as template for selective immobilization of negatively-charged 
streptavidin-coated beads by electrostatic interactions. We have shown that addition of a non-
ionic surfactant to the bead solution increases the selectivity of the micropatterning process. 
Streptavidin-coated magnetic beads (1 μm and 2.8 μm in size) were immobilized, with high 
reproducibility and in a very short processing time (~ 10 minutes), in the form of stripes and 
dots, both on bare substrates and in situ in microfluidic channels.  The arrangement and the 
number of immobilized beads can be controlled by tuning the aminosilane template size. We 
have also shown that magnetic forces can be used for speeding-up the electrostatic self-
assembly process (to less than a minute). The magnetic field-assisted patterning approach can 
be a useful tool to rapidly and densely self-assemble nanometer-size magnetic beads on a 
substrate, which otherwise would take several tens of minutes by sedimentation. 
 
Subsequently, we have demonstrated two microfluidic bio-applications based on 
electrostatically patterned streptavidin-coated magnetic beads. As the first application, we 
reported full on-chip sandwich immunoassays using mouse IgG (m-Ag) diluted in PBS-BSA 
solution as model target Ag. The fluorescent sandwich immuno-complex was formed on the 
beads during the operation of the chip both in stop-flow and continuous-flow mode. Target m-
Ag was detected down to a concentration of 15 ng/mL in stop-flow mode and 250 pg/mL in 
continuous-flow mode, using only 1300 nL of sample volume. We have shown that higher 
assay sensitivity can be achieved, either by increasing the incubated sample volume, by 
decreasing the number of beads in the incubation volume, or by operating the immunoassay in 
a continuous flow mode. Also, we have demonstrated the possibility of simultaneous detection 
of two different Ags m-Ag and rabbit IgG (r-Ag) in a PBS-BSA solution using a dual 
microfluidic channel structure. Thanks to the simple bead patterning approach and the 
possibility to functionalize dedicated bead patterns in a complex microfluidic manifold 
microstructure, we expect that our approach holds large potential for more complex multi-
analyte bioassays on-chip. As the second application, we have demonstrated a microfluidic 
chip-based specific separation of MCF-7 epithelial breast cancer cells from a mixed cell 
solution using functionalized beads, followed by culture, and immunocytochemical analysis by 
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time-resolved (TR) luminescence of a Eu-labeled 5D10 monoclonal Ab (mAb). One of the 
advantages of this approach is the short time required for micropatterning the beads inside a 
microchannel using a magnetic-field assisted electrostatic self-assembly technique. The second 
advantage lies in the bead lending itself to all classical techniques required for live cell 
targeting and subsequent culture based on the grafting of immuno-specific cell-capture ligands 
and cell-adhesion promoting proteins. The captured cells adhere and grow on the bead surface 
in a normal way, displaying an adequate morphology. Finally, decoration of the specific 5D10 
mAb with a lanthanide luminescent probe led to improved immunocytochemical analysis of the 
cultured cells. We believe that this integrated approach of cell capture in (patterned) areas of 
interest followed by their short-term culture and analysis on a single zone of a microfluidic 
chip, based on in situ self-assembled pre-functionalized beads can open doors for easier and 
quicker realization of bead-based labs-on-a-chip devices for cellomics studies. 
 
In the last part of this work, we have performed immunocytochemical assays on the cultured 
cancer cells for the detection of 5D10 Ag expression, which is associated with breast cancer. 
Initially, the conditions for growing MCF-7 (model positive cells) and HeLa cells (negative 
control cells) in 100-200 µm wide microchannels engraved in PDMS are determined and 
optimized. After the immunocytochemical assays, both conventional fluorescent detection and 
TR luminescent detection were performed and the results were compared. For fluorescent and 
luminescent detection, we used common FITC organic dye and Eu/Tb based lanthanide-
complexes as labels, respectively. Our on-chip immunocytochemical assay results showed that, 
in contrast to the fluorescent mode detection, the TR luminescence detection eliminated the 
background noise and thus resulted in a high sensitivity or signal-to-noise ratio. Based on these 
promising results, we further extended our approach for on-chip detection of three breast cancer 
markers, viz. ER, PR and Her2/neu on clinical human breast tissue samples.   We were able to 
perform multiplexed detection of a pair of biomarkers (ER and Her2/neu or PR and Her2/neu) 
using two different detection labels, i.e. Eu and Tb. The assay is ~ 6 times faster and requires 5 
times less reactants than conventional immunohistochemical analyses. The assay results were 
in good agreement with the clinical results. Consequently, combining TR luminescence 
detection based on lanthanide labels with microfluidics technology for the detection of tumor 
markers on human breast cancer tissues has led to a unique, fast, and cheap assays for single 
and as well as multiplexed detection of cancer markers. The improvement in analysis time and 
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the reduction in reagent consumption inherent to these new immunohistochemical analyses are 
substantial and could lead to improved diagnosis and better follow-up of cancer treatment. 
 
In a nut-shell, in this thesis we have reported a new method, based on electrostatic self-
assembly approach, for creating bead-based protein patterns on a glass substrate and in-situ 
inside a microfluidic channel. Based on the self-assembled protein-coated bead array, two 
different microfluidic bio-applications, viz. sandwich immunoassays and target cell separation 
and culture, were demonstrated. Also, we have demonstrated on-chip multiplexed detection of 
cancer biomarkers on cancerous tissues based on time-resolved imaging of lanthanide 
luminescence. 
7.2 Outlook 
Patterning of charged materials 
In this thesis, we have demonstrated the patterning of negatively-charged protein-coated beads 
using APTES patterns. However, several proteins are also positively-charged and hence it 
would of interest to directly pattern positively-charged protein-coated beads via electrostatic 
forces. Polyelectrolyte multilayers (PEM) have recently gained a lot of attention for patterning 
charged particles on a micro- and nanoscale. Both positively-charged and negatively-charged 
polyelectrolyte materials are available and it has been shown that they can be printed on a 
substrate using micro-contact-printing technique1-3. However, simple reliable methods (like the 
lift-off technique) to create PEM micropatterns on a full wafer scale are still not available. As a 
continuation of our work, simple techniques for creating PEM micropatterns could be 
developed.  
Magnetic bead micropatterns 
Though we have demonstrated the use of self-assembled magnetic beads as platform for 
performing microfluidic bioassays, one can envisage other interesting applications based on the 
former. For example, bead patterns can be used as the basis for developing cilia-like flexible 
permanent magnetic chains inside a microfluidic channel. These artificial-cilia structures can 
serve as bio-mimetic models for studying the bio-physics of ciliary pumping, mixing etc. The 
method for forming permanent magnetic chains has been demonstrated by the Bibette Group4-6. 
However, tethering these chains to the surface of a microchannel, at defined locations, has not 
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been demonstrated. Tethering of the chains at its bottom end is important to form an artificial 
cilia. For this purpose, single magnetic bead patterns can be used as a template for both 
growing and tethering permanent magnetic chains under the application of a homogeneous 
magnetic field.  
 
Additionally, patterned magnetic beads can be used as templates for the self-assembly and / or 
capture of other magnetic entities, that are suspended in a liquid sample, by acting as magnetic 
field concentrators under the application of an external magnetic field. 
Bead-based microfluidic bio-assays 
Immunoassays 
A passive microfluidic mixer can be integrated in the microchannel for enhancing the speed of 
analyte capture by the beads. For example, a herring-bone mixer could be used to direct the 
analyte present in a sample flow towards the microchannel surface7 and thus reduce the analyte 
interaction time many times, enhancing the assay sensitivity. Also, protein-coated bead arrays 
can be used as the basis for studying the interaction kinetics between the protein grafted on the 
bead surface and the interacting protein present in the sample flow. 
Target cell capture and culture 
We have demonstrated a simple and novel method for simultaneous capture and culture of 
target cells, in spatially-localized zones, using a double-protein (cell capture Ab and growth 
promoting fibronectin) approach. However, it is a known fact that the Abs are expensive. 
Instead, aptamers can be used as cheaper alternative to the Abs for the immunocapture of 
specific cells8, 9. So far, to demonstrate our concept, we have used only breast cancer cells 
(MCF-7) as model target cells. However, in future, it is important to perform experiments using 
other kinds of epithelial cells and to investigate whether the bead patterns can withstand the 
traction forces exerted by these cells when cultured. Also, using our approach for cell-capture 
and culture, multiplexed capture of different target cells and their subsequent co-culture could 
be possible, thus paving way for several important cell-based assays. 
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On-chip immunohistochemical assay on breast tissues 
As our on-chip immunohistochemical assay results were in good agreement with the results of 
the pathology laboratory of CHUV, Lausanne, as a next logical step, a double blind study of a 
large panel of routine samples (50-100 samples) could be performed for further validation of 
our results10. These samples should be transferred to us without any information on the results 
of the pathology lab. except the sample name. Thereafter, our results can be compared with the 
clinical results. This would take our device and the protocol under development closer to a 
surgery room cancer diagnostic application. 
Towards a lab-on-a-chip 
In this work, we have developed new methods for realizing full on-chip bio-assays. For the 
demonstration of our methods we have used PDMS-glass based microfluidic chips and a stand-
alone microscope equipped with a camera as detector. However, for the realization of a 
portable lab-on-a-chip device, a miniaturized optical fluorescence/luminescence detection unit 
has to be further integrated to the microfluidic device. Ideally, a plug-and-play lab-on-a-chip 
system, where, one can plug the APTES coated/tissue bearing glass slide into a work station 
and then run the bio-assay protocol in an automated fashion. 
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